The Automated Daily - Top News Edition

Please support this podcast by checking out our sponsors: - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Super-cleaner cells for Alzheimer’s - Washington University researchers reprogrammed astrocytes to recognize and clear amyloid beta, preventing plaques in mice and cutting existing plaques by about half—promising “one-and-done” Alzheimer’s therapy potential. Cheaper semaglutide generics on horizon - A new cost analysis suggests semaglutide could be produced for just a few dollars per month once patents loosen, potentially expanding Ozempic/Wegovy-style access for diabetes and obesity in lower-income markets. Warming is speeding up fast - A study across major temperature datasets finds human-driven warming has accelerated to roughly 0.35°C per decade since 2013–2014, tightening the timeline for crossing the Paris 1.5°C limit. UN warns on mineral security - The U.N. Security Council heard that demand for lithium, cobalt, and nickel could surge by 2030, making critical-mineral supply chains a strategic and geopolitical flashpoint amid U.S.–China tensions. Ukraine’s armed ground robots expand - Ukrainian forces are deploying more weaponised uncrewed ground vehicles to reduce troop exposure in drone-saturated battle zones, raising new legal and ethical questions around autonomy and targeting. Finland rethinks nuclear weapons ban - Finland proposes ending its long-standing legal ban on nuclear weapons presence, aligning more closely with NATO deterrence as Europe’s security calculus shifts after Russia’s invasion of Ukraine. Japan and Canada tighten ties - Japan and Canada signed a strategic roadmap covering defense cooperation, economic security, cyber dialogue, and energy supply resilience, reflecting Indo-Pacific tensions and Middle East-driven oil anxiety. Hormuz crisis hits global shipping - The U.S. announced up to $20 billion in maritime reinsurance to keep ships moving after Iran effectively shut the Strait of Hormuz, a chokepoint affecting oil prices, inflation risk, and supply chains. DART nudged an asteroid’s solar orbit - New research confirms NASA’s DART impact not only altered Dimorphos’s orbit around Didymos, but also measurably shifted the pair’s path around the Sun—an important real-world datapoint for planetary defense. Episode Transcript Super-cleaner cells for Alzheimer’s We’ll start in medical research, with a striking Alzheimer’s development. Scientists at Washington University School of Medicine engineered astrocytes—support cells in the brain—to act like targeted “clean-up crews” that recognize amyloid beta, the protein tied to Alzheimer’s plaques. In mouse studies, a single treatment given early prevented plaque buildup entirely over the next few months. And in older mice that already had heavy plaque levels, that same one-time approach reduced plaques by about half. The big reason this matters: today’s anti-amyloid therapies often mean repeated infusions over time, while a durable, one-and-done strategy—if it ever proves safe and effective in people—could dramatically reduce treatment burden. Researchers are also clear that more safety and targeting work is needed before this is anywhere near clinical use. Cheaper semaglutide generics on horizon Staying with health—and with questions of access—another new analysis is turning heads in the debate over GLP-1 medicines, the class that includes semaglutide, known widely through Ozempic and Wegovy. Researchers estimate generic versions could potentially be manufactured for just a few dollars per person per month, once patent barriers fall away and competition kicks in. The analysis leans on recent ingredient pricing data and points to upcoming patent expirations in several countries. If those timelines hold and manufacturing ramps up, the interesting part isn’t just cheaper meds in wealthy markets—it’s the possibility of much broader availability for diabetes and obesity treatment in low- and middle-income countries, where today’s prices put these drugs out of reach for most patients. Warming is speeding up fast Now to climate, where a new study argues the pace of human-caused warming has accelerated sharply over the past decade. After filtering out natural ups and downs—things like El Niño swings, volcanic effects, and solar variation—researchers found warming since around 2013–2014 has been running notably faster than the long-term late-20th-century trend. One implication is a tighter clock for the Paris Agreement’s 1.5°C threshold, potentially before 2030 if the recent pace persists. Scientists do still debate how much of the very latest jump is purely long-term forcing versus short-term variability, but the headline is hard to ignore: faster warming means less time to adapt and less margin for avoiding the kinds of heat extremes and knock-on impacts that are already becoming familiar. UN warns on mineral security From climate to the resources powering modern life: at the U.N. Security Council, officials warned that demand for critical minerals could triple by 2030 and quadruple by 2040. These are the materials behind batteries, electronics, and a lot of military hardware—so the conversation is no longer just about trade, it’s about national security and geopolitical leverage. The meeting came with U.S.–China rivalry in the background, especially after China tightened restrictions on certain rare earth exports. The U.S. message was essentially: no one wants a future where a single supplier can squeeze global industry. At the same time, countries that actually produce these minerals pushed another point—securing supply chains can’t mean tolerating conflict financing or weak governance. The next chapter here is likely to be a mix of new alliances, new mining deals, and much louder debates over what “responsible” extraction truly looks like. Ukraine’s armed ground robots expand Turning to the battlefield in Ukraine, the war’s robotics era is expanding beyond the skies. Ukrainian units say armed uncrewed ground vehicles—some used as remote weapons platforms, others as one-way explosive vehicles—are increasingly part of frontline tactics. Commanders emphasize that many systems are still only partly autonomous: machines can help with navigation and spotting, but humans are generally making the final decision to fire. That distinction matters, both ethically and legally, especially with civilians and identification risks. Strategically, the push reflects brutal battlefield reality: aerial drones have widened the danger zone, making routine movement more deadly, while manpower shortages raise the value of systems that can hold positions or probe defenses without exposing soldiers. Russia is also fielding its own ground robots, setting the stage for more frequent machine-versus-machine encounters. Finland rethinks nuclear weapons ban In Northern Europe, Finland is signaling another major shift in how it thinks about deterrence. The government is proposing changes that would end a decades-old legal ban on bringing, possessing, or transporting nuclear weapons on Finnish territory. Officials argue the security environment has fundamentally changed since Russia’s full-scale invasion of Ukraine, and they say the update would better align Finland with NATO’s posture. The proposal still has to move through consultation and parliament, but Finland’s political direction since joining NATO has been unmistakable—especially with its long border with Russia. More broadly, it’s another example of how the Ukraine war continues to reshape defense assumptions across Europe, including issues that used to be politically untouchable. Japan and Canada tighten ties Across the Pacific, Japan and Canada have signed a strategic agreement in Tokyo aimed at tighter cooperation on defense, economic security, cyber policy, and energy resilience. The timing is notable: concerns over oil supply stability have been rising as tensions in the Middle East spill into market anxiety. Alongside energy, the deal reflects shared worries about coercive trade practices and a tougher security environment in the Indo-Pacific. The two countries also plan to start negotiations on a defense pact meant to smooth military visits and joint exercises. Taken together, it’s another sign that middle powers are weaving a denser web of partnerships—partly to hedge against shocks, and partly to reduce dependence on any single route, supplier, or security guarantor. Hormuz crisis hits global shipping That brings us directly to the Middle East and the shipping shock now rippling outward. The United States announced a new arrangement offering up to twenty billion dollars in maritime reinsurance coverage, including war-risk protection, to help keep commercial vessels operating despite the conflict with Iran. This comes after Iran effectively closed the Strait of Hormuz by threatening ships attempting to transit the narrow corridor—one of the world’s most critical chokepoints, carrying a huge share of global oil. As private insurers raise premiums, voyages can become uneconomical fast, and that translates into delayed deliveries, higher transport costs, and upward pressure on fuel prices—feeding inflation well beyond the region. The policy goal here is straightforward: keep coverage available, keep ships moving, and prevent a security crisis from turning into a deeper economic one. DART nudged an asteroid’s solar orbit Finally, a story that’s small in numbers but big in meaning: NASA’s DART mission—the deliberate crash into the asteroid moonlet Dimorphos—did more than alter Dimorphos’s orbit around its companion. New research says it also measurably shifted the pair’s orbit around

Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Alzheimer’s super-cleaner brain cells - Washington University researchers used a CAR-style gene to turn astrocytes into amyloid-beta “cleaners,” preventing plaques in mice and cutting existing plaques by about half. Keywords: Alzheimer’s, amyloid, CAR, astrocytes, Science. AI model for whole genomes - Evo 2, a genome language model trained on OpenGenome2, aims to generalize across species and help interpret variants, genes, and regulatory DNA. Keywords: genome AI, foundation model, variant scoring, long context, biosafety. Cancer vaccines aimed at relapse - An NHS-backed study is testing personalized mRNA cancer vaccines with immunotherapy to reduce recurrence risk, highlighted by a head and neck cancer patient’s participation. Keywords: mRNA vaccine, immunotherapy, relapse prevention, clinical trial, head and neck cancer. GLP-1 drugs and addiction signals - A large VA records study links GLP-1 diabetes drugs with fewer overdoses, substance-related deaths, and lower risk of new substance use disorders—raising hopes but needing trials. Keywords: semaglutide, tirzepatide, addiction, overdose, observational study. Critical minerals become security issue - At the U.N. Security Council, officials warned demand for lithium, cobalt, and nickel could surge, making supply chains a strategic flashpoint in the energy transition and defense. Keywords: critical minerals, supply chain, China, energy transition, security. Finland rethinks nuclear weapons ban - Finland is proposing changes that would lift a long-standing legal ban on nuclear weapons on its territory, reflecting NATO deterrence realities after Russia’s invasion of Ukraine. Keywords: Finland, NATO, deterrence, Russia, nuclear policy. Russia oil, India, Hormuz risks - As fears grow of conflict disrupting Middle East oil flows, Russia is preparing to redirect crude toward India, spotlighting India’s limited reserves and Hormuz exposure. Keywords: oil security, India, Hormuz Strait, Russia exports, geopolitics. Broadcom’s massive AI chip bet - Broadcom beat expectations and its CEO projected AI chip revenue next year could top $100 billion, signaling sustained demand for custom AI silicon beyond standard GPUs. Keywords: Broadcom, custom AI chips, data centers, guidance, OpenAI. U.S. may tighten AI chip exports - The Trump administration is weighing rules that could require approval for nearly all overseas AI chip shipments, potentially slowing sales and reshaping global supply chains. Keywords: export controls, Commerce Department, Nvidia, AMD, China. China’s push for flying taxis - AutoFlight demonstrated a large eVTOL prototype in China, underscoring Beijing’s ‘low-altitude economy’ ambitions—though commercial passenger flights remain years away. Keywords: eVTOL, flying taxi, low-altitude economy, certification, infrastructure. Episode Transcript Alzheimer’s super-cleaner brain cells We’ll start with that Alzheimer’s headline, because it’s the kind of idea that makes researchers lean forward. A team at Washington University School of Medicine reported they engineered astrocytes—support cells in the brain—to act like targeted “super cleaners.” The twist is borrowed from cancer medicine: they used a harmless virus to deliver a gene that helps these cells recognize amyloid beta, the protein that builds up into Alzheimer’s-linked plaques. In mice that were destined to develop plaques, one injection given early kept them plaque-free for months. And in older mice that already had heavy plaque buildup, the same one-time treatment cut plaque levels by about half. It’s early-stage and still a long road to human testing, but the appeal is obvious: today’s anti-amyloid antibody therapies can mean repeated infusions, while a durable, single intervention—if it proves safe—could change the burden on patients and families. AI model for whole genomes Staying in medical research, there’s another story pointing to more personalized treatment—this time in cancer. In the U.K., an NHS-backed trial is testing personalized cancer vaccines designed to reduce the odds of the disease returning, with one participant describing it as a chance to help push the science forward after being treated for advanced head and neck cancer. The key idea is tailoring an mRNA-based vaccine to the individual tumor, alongside immunotherapy, to help the immune system spot lingering cancer cells. It’s not a guarantee and it’s not a standard-of-care yet—but it reflects a broader shift: oncology is moving from one-size-fits-all regimens toward therapies tuned to the patient’s specific cancer signature. Cancer vaccines aimed at relapse Another health development is raising eyebrows for a different reason: diabetes drugs that may be doing more than managing blood sugar and weight. A large observational analysis using U.S. Veterans Affairs health records—over 600,000 people with Type 2 diabetes—found that patients prescribed GLP-1 medications were linked to markedly better addiction-related outcomes. Among people who already had substance use disorders, GLP-1 use was associated with fewer overdoses, fewer substance-related deaths, and fewer suicide attempts over a multi-year period. And among people without prior substance use disorders, GLP-1 users showed a lower likelihood of developing problems with alcohol, opioids, cocaine, or nicotine. Important caveat: this isn’t proof of cause and effect. But it adds weight to the idea that these drugs may dampen cravings by acting on brain reward circuits—an intriguing possibility in a field where treatment options are still far too limited. GLP-1 drugs and addiction signals Now to the intersection of biology and AI: researchers are out with a new “genome language model” called Evo 2, trained across a wide span of life—bacteria, archaea, eukaryotes, and even phages—using a newly curated dataset. The significance isn’t the hype around bigger models; it’s what long context means for biology. Evo 2 is designed to read extremely long stretches of DNA in one go, which matters because many important genetic signals are spread out—especially in complex organisms. The team says the model can help score how damaging certain genetic changes might be, flag gene features, and even generate long DNA sequences in silico. They also deliberately limited some viral data for safety reasons, a reminder that powerful bio-AI comes with governance questions, not just scientific opportunity. Critical minerals become security issue Let’s widen the lens to geopolitics, starting with what the U.N. is warning could become the next big choke point: critical minerals. At the Security Council, the U.N.’s political chief said demand for minerals used in everything from phones to missiles could triple by 2030 and quadruple by 2040. She also pointed to how enormous this market already is—trade in raw and semi-processed minerals reaching into the trillions of dollars. Why it matters: these materials sit at the crossroads of the energy transition and national security. The meeting underscored a reality governments are increasingly saying out loud—supply chains for lithium, cobalt, nickel, and rare earths are now strategic terrain, not just commerce. And that raises pressure for “responsible mining” that doesn’t bankroll conflict or corruption, especially in resource-rich regions already under strain. Finland rethinks nuclear weapons ban Europe’s security rethink is also showing up in Finland, where the government is proposing to end a decades-old legal ban that prevents nuclear weapons from being brought onto Finnish territory. Officials argue the security environment has fundamentally changed since Russia’s full-scale invasion of Ukraine, and that Finland’s posture should align more closely with NATO’s deterrence framework. This is not Finland announcing it wants nuclear weapons of its own. It’s about legal flexibility—making room for NATO-linked defense arrangements that would have been politically unthinkable just a few years ago. With Finland sharing NATO’s longest border with Russia, the proposal is a vivid example of how the war in Ukraine continues to rewire policies across the region. Russia oil, India, Hormuz risks Energy security is another area where geopolitics is translating into real-time planning. Japanese media report Russia is preparing to redirect part of its crude oil exports toward India amid fears that a U.S.-Israel strike on Iran could disrupt global supplies. A tanker carrying millions of barrels of Russian crude is said to be moving near Indian waters, potentially arriving within weeks. What makes this story tense is India’s vulnerability to disruption: limited domestic stockpiles and heavy exposure to oil flows that pass through the Strait of Hormuz. Russia is signaling it could cover a large share of India’s needs if a prolonged crisis hits—but ultimately, the decision would hinge on India’s government, balancing energy needs against sanctions pressure and shifting relationships with Washington and Beijing. Broadcom’s massive AI chip bet On the business and tech front, Broadcom delivered a major moment for the AI infrastructure story. The company beat expectations, issued upbeat guidance, and its CEO said he expects next year’s AI chip revenue to be well above one hundred billion dollars. That number is striking not just for its scale, but for what it implies: the AI boom is maturing into a phase where big players increasingly want custom chips designed for their specific workloads, not just off-the-shelf accelerators. Broadcom is positioning

Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Iran war spreads across region - Missile and drone attacks tied to the Iran war are causing casualties, airspace closures, and shipping risk around the Strait of Hormuz—raising global energy and trade stakes. Russia offers oil to India - Russia is preparing to redirect crude exports toward India as Middle East supply risks rise; India’s limited stockpiles and heavy Hormuz reliance make energy security a top issue. China’s Five-Year Plan goes AI - At China’s “Two Sessions,” Beijing’s new five-year blueprint highlights an “AI+” push, quantum and robotics, and self-reliance in chips—amid weak consumption and U.S. tech tensions. Broadcom bets big on AI chips - Broadcom posted strong results and projected massive AI chip revenue, underscoring the shift toward custom AI silicon and the ongoing buildout beyond standard GPU supply. Evo 2 brings genome-scale AI - Researchers unveiled Evo 2, a genome language model trained across the tree of life, showing strong variant scoring and genome annotation signals—while emphasizing biosafety-driven limits. New fronts in medicine and care - From personalized cancer vaccines to a simplified HIV pill and injectable “satellite livers,” multiple studies aim to make long-term treatment easier and more accessible for patients. GLP-1 drugs and addiction signals - A large U.S. VA records study links GLP-1 diabetes drugs like semaglutide and tirzepatide with fewer overdoses and substance-related deaths, hinting at a potential new tool for addiction care. Episode Transcript Iran war spreads across region We’ll start in the Middle East, where the escalating war involving Iran is rippling outward fast. Reports describe missile strikes, drone attacks, and even falling debris causing deaths and injuries across multiple countries. Beyond the human toll, what’s drawing global attention is the knock-on effect: airports shutting down, embassies reducing operations, and airspaces closing in a region that sits at the center of global energy and shipping routes. Russia offers oil to India On the ground, Iran has reportedly taken heavy damage from U.S.-Israeli strikes aimed at nuclear and missile infrastructure and government-linked sites. Israel, meanwhile, has also been hit, including deadly strikes that damaged buildings in and around Tel Aviv and near Jerusalem’s Old City. Lebanon is seeing displacement and casualties as Israel targets Hezbollah-linked positions and moves forces near the border, while Hezbollah says it’s launching drones toward Israeli military sites. Gulf states have reported incidents affecting diplomatic facilities and energy operations, prompting wider disruptions. China’s Five-Year Plan goes AI What makes this especially consequential is the economic geometry of the region. Aviation is in chaos as routes are canceled and detoured. Shipping risk is rising around the Strait of Hormuz, and that’s the chokepoint markets watch because so much oil and gas moves through it. The AP also highlights how far the conflict’s footprint has spread, including an incident off Sri Lanka involving a U.S. submarine and an Iranian warship—plus rescues and recovery efforts at sea. Even if details evolve, the message to markets is already clear: instability is no longer contained to one front. Broadcom bets big on AI chips That brings us to energy security in Asia. According to sources, Russia is preparing to redirect some crude exports toward India as fears grow that Middle East supply could be disrupted. A ship—or ships—carrying a large volume of Russian crude is reportedly near Indian waters, potentially arriving within weeks. The bigger story here is India’s vulnerability: limited crude stockpiles and a major dependence on imports that typically pass through the Strait of Hormuz. If the conflict drags on, India is looking for alternative supply options—and Russia is signaling it’s ready to step in, though how much India takes is ultimately a political decision as much as an economic one. Evo 2 brings genome-scale AI Next, to China, where leaders are meeting in Beijing for the annual “Two Sessions.” The headline is the new five-year policy blueprint: it leans hard into artificial intelligence, advanced manufacturing, and strategic tech independence. In plain terms, Beijing is saying it doesn’t just want breakthroughs in labs—it wants those breakthroughs deployed at scale across factories, cities, and public services. New fronts in medicine and care The plan repeatedly emphasizes AI and includes an “AI+” approach: putting AI into more corners of the economy, from automation in labor-short industries to software agents that can complete tasks with minimal supervision. It also calls out long-horizon bets—quantum technology, robotics, next-generation networks, and other frontier areas. The stakes are high because China is trying to pull this off while facing weak household consumption, a property-sector hangover, deflationary pressure, and a shrinking population—plus continued trade and tech friction with the United States. Watch for whether Beijing pairs its tech push with stronger measures to boost consumer demand at home, because that balance will shape global competition and trade tensions. GLP-1 drugs and addiction signals In U.S. tech business news, Broadcom delivered earnings and guidance that beat expectations—and then went a step further. CEO Hock Tan told analysts he expects next year’s AI chip revenue to be far above a hundred billion dollars. Investors took the hint, pushing the stock up in after-hours trading. What’s notable isn’t just the size of the forecast; it’s the direction of travel: major customers are leaning into custom-built AI chips and the infrastructure to support them, even as the industry wrestles with bottlenecks like specialized memory and advanced manufacturing capacity. Broadcom’s message is that the custom-AI buildout is moving from experiment to a more industrial “next phase.” Story 8 Now to a major research development in biological AI. Scientists are reporting “Evo 2,” described as a large genome language model trained on a newly curated dataset spanning bacteria, archaea, eukaryotes, and phage. The interesting twist is the goal: rather than tuning for one narrow task, the model is built to learn broad patterns in biological sequences—something like a foundation model for genomes. Story 9 Why does that matter? In benchmarks, Evo 2’s scores track signals you’d expect from evolution—helping it estimate which changes in DNA are likely to be harmful or tolerated. Researchers report it does especially well on more complicated kinds of variants, like insertions and deletions, not just single-letter changes. They also describe methods to make the system less of a black box by extracting internal features that line up with recognizable biology—like DNA motifs and exon–intron boundaries. And, importantly, the team intentionally limited performance on certain virus categories by excluding data for biosafety reasons, putting safety trade-offs right next to capability claims. Story 10 The generative side is what will grab a lot of attention: Evo 2 can produce very long DNA-like sequences that resemble small genomes in simulations. The authors stress that “looking right” isn’t the same as working in living cells. Still, they also report guided DNA generation aimed at achieving specific gene-regulation patterns, with experimental checks in mouse and human cells. If that line of work holds up, it points toward more programmable biology—alongside harder questions about governance as these tools become more powerful and more widely available. Story 11 Let’s shift to healthcare, where several studies point in the same direction: simpler, more personalized treatment. In the UK, a patient in Leeds, Richard Oldale, spoke about joining a major NHS-backed trial testing personalized cancer vaccines designed to reduce the risk of cancer returning. The vaccine approach uses mRNA alongside immunotherapy to help the immune system recognize cancer-specific targets. Beyond one person’s story, the wider significance is that individualized vaccines are moving from concept to large trials, and regional research centers could become gateways for broader access—if the results support it. Story 12 In HIV care, researchers reported results suggesting a once-daily single pill could replace complex multi-pill regimens for a subset of patients who can’t use standard simplified options because of resistance or drug interactions. In studies involving hundreds of participants, the new approach controlled the virus about as well as the more complicated schedules. If regulators agree, the practical upside is straightforward: fewer pills usually means fewer missed doses, which helps keep viral load suppressed—benefiting both individual health and transmission prevention. Story 13 And in regenerative medicine, MIT engineers described injectable “satellite livers”—small engineered grafts that, in mice, formed stable mini-organs in fatty tissue, connected to blood supply, and supported liver function for weeks. This isn’t a near-term replacement for full transplants, but it hints at a future “bridge” therapy: helping patients who can’t get an organ in time, or who are too ill for major surgery, while researchers work through big challenges like immune rejection. Story 14 Finally, a surprising signal from a very large U.S. observational study: using Veterans Affairs health records, researchers looked at over 600,000 people with type 2 diabetes and found th

Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Middle East conflict escalates rapidly - U.S.-Israeli strikes on Iran and regional retaliation intensified, with missile and drone attacks, major casualties, and disruption to flights, shipping, and energy markets. Key keywords: Iran, Israel, Gulf states, Hormuz, escalation, casualties. AI contracts and wartime guardrails - OpenAI said it will revise a U.S. government deal for classified military use after backlash, adding clearer limits around domestic surveillance and tightening access for intelligence agencies. Key keywords: OpenAI, Altman, NSA, surveillance limits, military AI, human-in-the-loop. Neuron-powered computer plays Doom - Australia’s Cortical Labs showed a hybrid “biocomputer” using living human neurons that can learn a simplified version of Doom, a milestone for adaptive learning beyond earlier Pong tests. Key keywords: Cortical Labs, neurons, biocomputer, Doom, adaptive learning, robotics potential. Single-pill option for HIV - A Lancet study suggests a once-daily single tablet combining bictegravir and lenacapavir could simplify treatment for HIV patients who can’t use standard one-pill regimens due to resistance or interactions. Key keywords: HIV, adherence, drug resistance, Gilead, FDA approval, viral suppression. Gravitational waves and Hubble tension - Researchers propose using the gravitational-wave background as an independent way to estimate the universe’s expansion rate, potentially helping resolve the Hubble tension. Key keywords: Hubble constant, LIGO, gravitational waves, stochastic background, cosmology discrepancy. China’s Two Sessions tech push - China’s leadership meets in Beijing for the Two Sessions, with the next Five-Year Plan expected to double down on scaling advanced technologies while navigating weak consumption and geopolitical friction. Key keywords: Two Sessions, Five-Year Plan, semiconductors, AI, manufacturing, trade tensions. Rare earths and uranium partnerships - India and Canada signed a uranium supply agreement, while Japan and India discussed jointly developing new rare earth deposits to reduce reliance on China for critical minerals. Key keywords: uranium, nuclear energy, rare earths, supply chains, EV magnets, diversification. AI chatbots for health risks - Health-focused AI chatbots are growing popular for interpreting test results and prepping for doctor visits, but experts warn about privacy gaps and the risk of misleading guidance for urgent symptoms. Key keywords: ChatGPT Health, medical advice, HIPAA, privacy, hallucinations, clinical safety. Episode Transcript Middle East conflict escalates rapidly We start in the Middle East, where the U.S.-Israeli campaign against Iran, and Iran’s retaliation across the region, continued into Monday with widening fallout. Iran and Iran-aligned militias launched missiles and drones that hit Israel and multiple Gulf states, with reports that the U.S. Embassy compound in Kuwait was struck. The U.S. military also said Kuwaiti air defenses mistakenly shot down three American F-15E jets during combat operations—one of those rare moments that signals just how chaotic high-tempo air warfare can get. On the ground, Iranian attacks in Kuwait reportedly killed six U.S. Army soldiers and seriously wounded more troops. Iran’s Red Crescent said at least 555 people have been killed in Iran since the U.S.-Israeli strikes began, and claimed more than 130 cities have been hit. Meanwhile, Israel expanded operations against Hezbollah in Lebanon after additional rocket and drone attacks, including strikes tied to Hezbollah-aligned media and financial-linked sites. Diplomatically and economically, the shockwaves are growing: the U.S. urged Americans to leave several countries in the region, airlines rerouted and canceled flights, and energy markets reacted after QatarEnergy halted LNG production and shipping through the Strait of Hormuz reportedly dropped sharply. If that chokepoint stays disrupted, the ripple effects won’t be confined to the region. There’s also political uncertainty inside Iran. Reports say Iran is moving toward appointing a new supreme leader after Ayatollah Ali Khamenei’s reported killing—an extraordinary claim with potentially huge consequences if confirmed over time. And one more escalation signal: a report says the U.S. and Israel may be trying to encourage an armed uprising inside Iran by backing a Kurdish force and smuggling weapons into western Iran. Iran, in turn, has stepped up attacks in Kurdish areas and reinforced its presence there. Whether that effort succeeds or backfires, it suggests the conflict’s aims could be broadening beyond airstrikes—raising the risk of a much longer and more unpredictable confrontation. AI contracts and wartime guardrails That conflict also ties into another major storyline: how quickly commercial AI tools are being pulled into military and intelligence work. OpenAI says it will amend its recent U.S. government agreement for using its technology in classified military operations after critics described the deal as rushed and unclear. Sam Altman said revisions will include explicit limits meant to prevent intentional domestic surveillance of U.S. persons, and that additional changes would be required before agencies like the NSA can use the system. The backlash didn’t stay inside policy circles. Reports suggest a noticeable spike in ChatGPT app uninstalls, while competitor Anthropic’s Claude surged in app rankings—an example of how trust, not just features, can move markets overnight. More broadly, this episode is renewing scrutiny of AI in wartime settings, especially as governments pair commercial models with platforms used to fuse intelligence and speed analysis. The central concern is simple: when decisions carry life-and-death consequences, errors, false confidence, or misleading outputs aren’t just bugs—they can become events. Expect more pressure for clearer guardrails, transparency, and strong “human-in-the-loop” requirements, particularly in lethal contexts. Neuron-powered computer plays Doom From geopolitics to a very different kind of intelligence: in Australia, startup Cortical Labs says its neuron-powered “biocomputer” has learned to play the classic shooter Doom. The headline isn’t that it’s good at Doom—it isn’t. The performance is still rough, and it loses often. What’s noteworthy is that the company is pushing beyond earlier demonstrations like Pong, and arguing it’s showing adaptive learning in real time using a hybrid setup: living human neurons interfacing with a chip. Engineers also had to translate what’s happening in the game into signals the neurons could respond to, since the cells can’t simply “see” a screen. An independent developer reportedly built the Doom interface quickly thanks to a programmable software setup, which hints at a faster pace of experimentation. Why this is interesting: if these interfaces keep improving, neuron-based systems could someday be trained for practical tasks—think robotics control or complex pattern learning—though for now, this remains early-stage science with more promise than polish. Single-pill option for HIV Now to health news with real near-term impact: a new study suggests a single, once-daily pill could simplify HIV treatment for a group of patients often left behind by today’s standard one-tablet regimens. Research published in The Lancet tested a tablet combining bictegravir and lenacapavir in about 550 people who currently rely on complicated multi-pill schedules—often because of drug resistance or interactions with other medications. The new pill controlled HIV just as well as those complex regimens. Separately, another study presented at a major HIV conference reported the same combination performed comparably to Biktarvy, a widely used first-line treatment. The big takeaway is adherence. HIV therapy is lifelong, and simpler routines tend to be easier to stick with—especially over years and decades. Keeping viral load suppressed isn’t only good for the patient; it also reduces transmission risk. Experts also stress the long game: HIV mutates, resistance evolves, and new combinations help stay ahead of a future where current options don’t work. Gilead says it plans to seek FDA approval soon. The next question is access—particularly in lower-income countries where most people living with HIV are—because the public-health value depends on availability, not just approval. Gravitational waves and Hubble tension Let’s zoom out to the cosmos. Scientists from the University of Illinois Urbana-Champaign and the University of Chicago are proposing a fresh way to measure how fast the universe is expanding—using gravitational waves—to help untangle the long-running “Hubble tension.” That tension is basically a stubborn disagreement: when astronomers measure the expansion rate using nearby objects like Type Ia supernovas, they get a faster universe than what you infer from the early universe using the standard cosmology model. The new approach looks at the gravitational-wave background—a faint, collective hum expected from countless distant black-hole mergers. The researchers argue its overall strength should line up differently depending on the true expansion rate. Using existing LIGO-Virgo-KAGRA data, they report results that lean toward a higher Hubble constant, meaning faster present-day expansion. Even though that background hasn’t been directly detected yet, the method matters because it could become an independent cross-check—helping scientists determine whether today’s mismatch is fro

Please support this podcast by checking out our sponsors: - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: War escalates after Iran strike - The U.S. and Israel launched major strikes on Iran, killing Ayatollah Ali Khamenei, and Iran retaliated across the region—raising fears of an open-ended war and wider instability. First combat use of Iron Beam - Israel says its Iron Beam laser air-defense system intercepted incoming threats in its first operational use, signaling a new layer in air defense amid regional escalation. How media labels conflict “war” - The Associated Press says the scale of attacks and retaliation now meets the definition of “war,” highlighting why newsroom wording matters for public understanding and policy debates. Legal backlash over Iran campaign - Analysts and legal experts are questioning the strikes’ legality under international law and U.S. war powers, warning that leadership “decapitation” without an endgame can fuel chaos and blowback. OpenAI tightens military AI limits - OpenAI says it will revise a U.S. government classified-use agreement to add explicit limits against intentional domestic surveillance and tighten conditions for intelligence-agency access. OpenAI mega-round and IPO path - OpenAI is raising a massive funding round with backing from Amazon, Nvidia, and SoftBank, positioning itself for more infrastructure and an anticipated 2026 IPO amid booming ChatGPT demand. Nvidia’s photonics supply-chain bet - Nvidia is investing billions in Lumentum and Coherent to strengthen photonics and optical networking supply chains—critical plumbing for AI data centers and next-gen communications. AI chatbots for health questions - Doctors say AI health chatbots can help explain test results and prep for appointments, but errors, privacy gaps outside HIPAA, and dangerous symptom triage remain key risks. Neuron biocomputer plays Doom - Cortical Labs showed lab-grown human neurons linked to a chip can learn to play Doom at a basic level, hinting that neuron-based computing may someday train for real-world control tasks. India-Canada uranium energy pact - India and Canada signed a uranium supply deal to support India’s nuclear power plans, deepening energy security ties alongside talks on renewables and advanced tech cooperation. Episode Transcript War escalates after Iran strike First, the biggest story: a major U.S.-Israeli air campaign against Iran has killed Iran’s Supreme Leader, Ayatollah Ali Khamenei, along with other senior figures. Iran has confirmed his death and announced a temporary leadership setup, but analysts are warning that removing the top leader doesn’t automatically dismantle the state—or end the conflict. Iran’s retaliation has been swift and wide: missiles and drones aimed at Israel, Gulf cities, and U.S. facilities in places including Bahrain, Qatar, and Kuwait. The reporting points to civilian casualties on multiple sides, as well as U.S. service members killed or wounded. Beyond the immediate destruction, what’s drawing concern is the absence of a clear endgame—because once escalation starts moving across borders and bases, it’s hard to put the brakes on. First combat use of Iron Beam That uncertainty is feeding a deeper debate over what comes next for Iran and the region. Some experts argue Israel may accept a weakened, fragmented Iran, while the U.S. and Gulf partners fear a collapse scenario—refugee flows, border instability, and long-term spillover. There’s also a familiar warning being raised: removing a dictator without a credible stabilization plan can leave a vacuum that turns into years of disorder, not a clean transition. Comparisons to Libya are showing up for a reason—because the “day after” can become the real conflict. How media labels conflict “war” As the fighting grows, language is changing too. The Associated Press says it is now calling this a “war,” arguing that the intensity, casualties, and reciprocal attacks between states meet standard definitions—even without formal declarations. It might sound like semantics, but it shapes how the public understands the stakes, and how history records the moment. AP also noted it avoids using the word lightly, precisely because overusing “war” for smaller actions can dull the meaning when a truly large-scale conflict erupts. Legal backlash over Iran campaign Legal and political backlash is building alongside the military action. An analysis from RNZ and The Conversation argues the strikes were not lawful under international law, saying they don’t meet the narrow standard for preemptive self-defense and lacked U.N. Security Council authorization. The piece also says diplomacy around Iran’s nuclear program was still underway when the strikes happened, and that bombing during negotiations undermines the idea of good-faith talks. In the U.S., questions are also surfacing about war powers and oversight—especially as the conflict expands and the costs, human and economic, become harder to contain. OpenAI tightens military AI limits Meanwhile, Israel says it has just crossed a new threshold in air defense: the first confirmed operational combat use of its Iron Beam laser system. According to Israel’s Defense Ministry, the laser intercepted incoming threats during a large Hezbollah missile barrage from Lebanon. Supporters are pitching it as a practical shift—because lasers, in theory, can reduce reliance on expensive interceptor missiles for smaller threats like drones and short-range rockets. But experts also point out the limitations: performance can drop in bad weather, and this system is meant to complement existing defenses, not replace them. Still, in a region where barrages can come in waves, any tool that changes the cost equation will get attention—and likely spur more demand. OpenAI mega-round and IPO path Now to the AI economy, where the spending—and the scrutiny—keep accelerating. OpenAI says it will amend a recent agreement with the U.S. government tied to classified military operations, after criticism that the deal looked rushed and overly broad. CEO Sam Altman says the changes will add explicit limits meant to prevent intentional domestic surveillance of U.S. persons, and will require extra modifications before intelligence agencies can use the system. The public blowback appears to have had immediate consequences: reports describe a surge in ChatGPT app uninstalls, while Anthropic’s Claude climbed app rankings. The bigger issue here is trust—because as AI tools move closer to sensitive decision-making, the fine print starts to matter as much as the model itself. Nvidia’s photonics supply-chain bet At the same time, OpenAI is pursuing a huge new funding round that would put its valuation in territory usually reserved for the largest public companies. The round includes major names—Amazon, Nvidia, and SoftBank—and it’s expected to close ahead of an anticipated IPO later in 2026. A key detail: under the Amazon agreement, OpenAI would tap massive new computing capacity and AWS would become the exclusive third-party cloud provider for OpenAI’s enterprise agent platform, while Microsoft remains central for OpenAI APIs and first-party products hosted on Azure. The takeaway is that the AI arms race is increasingly an infrastructure race—who can secure power, chips, and data-center capacity fast enough to meet demand. AI chatbots for health questions That infrastructure theme shows up again with Nvidia, which announced it will invest a combined four billion dollars in two U.S.-based photonics companies, Lumentum and Coherent. Photonics—think light-based components for moving data—matters because AI data centers are hitting bandwidth and energy limits, and faster optical links can help keep giant systems connected. Nvidia is framing this as part research push, part supply-chain strategy: lock in access to critical components while demand for “AI factories” keeps ballooning. It’s another sign that the bottlenecks in AI aren’t just about software—they’re about the physical plumbing of the internet’s next phase. Neuron biocomputer plays Doom On the consumer side of AI, health chatbots are becoming the new front door for everyday medical questions. Companies are rolling out health-focused versions, and clinicians say they can genuinely help—especially for summarizing confusing test results, spotting patterns in records, or helping people prepare for doctor visits. But the warnings are blunt: if you have serious symptoms like chest pain, shortness of breath, or a sudden severe headache, don’t debate with a chatbot—seek urgent care. There’s also a privacy gap many people miss: health data shared with chatbot companies typically isn’t protected by HIPAA, because those rules apply to many healthcare providers, not most AI developers. And while chatbots can do well on written scenarios, they can still mix accurate and inaccurate guidance in real conversation—sometimes in ways users don’t catch. India-Canada uranium energy pact Finally, a story that sounds like science fiction but is very real: Australian startup Cortical Labs has demonstrated a hybrid “biocomputer” powered by lab-grown human neurons that can learn to play the classic shooter Doom. This builds on the company’s earlier Pong work, and the headline claim is adaptive, real-time learning in a system where living cells interface with a chip. One of the big hurdles wasn’t teaching the game itself—it was giving the neurons a way to interpret what was happening on screen without normal vision. Engineers translated the game’s information into electrical patterns the cells could respond to. To be clear, performance is still rough: it loses often and isn’t anywher

Please support this podcast by checking out our sponsors: - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Israel debuts Iron Beam laser - Israel says its Iron Beam laser air-defense system intercepted incoming Hezbollah rockets in its first real combat use, a milestone for directed-energy weapons and layered air defense. U.S.-Israel strikes and retaliation risks - The U.S. confirmed first-ever combat use of American-made one-way attack drones in strikes on Iran under “Operation Epic Fury,” as regional escalation and retaliation risks climb. Oil markets watching Strait of Hormuz - Analysts warn the biggest oil shock would come if Iran disrupts shipping through the Strait of Hormuz, a critical chokepoint for crude and LNG, with potential spikes toward $100 oil. AI infrastructure spending hits overdrive - A global AI buildout is accelerating across data centers, GPUs, and power, with hyperscalers planning nearly $700bn in 2026 capex alone and growing pressure on grids and construction. OpenAI’s $110bn funding round - OpenAI is raising $110bn at a reported $730bn pre-money valuation, with Amazon, Nvidia, and SoftBank committing major sums alongside new compute and cloud arrangements. Nvidia pours money into photonics - Nvidia plans $4bn in combined investments and multi-year purchase commitments with Lumentum and Coherent to expand silicon photonics, lasers, and optical networking for AI data centers. Vietnam launches broad AI law - Vietnam’s new AI law, the first comprehensive framework in Southeast Asia, mandates labeling of AI-generated content and human oversight, echoing key elements of the EU AI Act. Canada and India reset ties - Canada and India agreed to new cooperation including a 10-year nuclear energy pact, while aiming to finalize a free trade agreement by end of 2026 after a period of strained relations. Episode Transcript Israel debuts Iron Beam laser First, the security picture. The U.S. military says it used kamikaze-style “one-way attack” drones in strikes on Iran over the weekend—reportedly the first time the United States has employed that category of weapon in combat. U.S. Central Command said Task Force Scorpion Strike used the drones during what it called “Operation Epic Fury,” describing them as low-cost systems modeled on Iran’s Shahed drones. An image released by Central Command showed a system identified as LUCAS, which reporting says is derived from the Shahed-136 design—a loitering munition that’s also been seen in Russia’s war in Ukraine. The message from Central Command was blunt: low-cost drones are no longer a tool only America’s adversaries can deploy at scale. U.S.-Israel strikes and retaliation risks In Israel, the weekend also delivered a notable “first.” Israel’s Defense Ministry confirmed the first operational combat use of its Iron Beam laser air-defense system, saying it intercepted a large barrage of Hezbollah missiles launched from Lebanon late Sunday night. Iron Beam, developed by Rafael and Elbit, is designed to complement Israel’s existing air-defense layers. The basic appeal is economics and logistics: instead of firing pricey interceptor missiles, a laser can engage smaller threats—like rockets, drones, and mortars—so long as there’s power available. Israeli officials have framed that as an effectively “bottomless magazine,” although experts continue to note the limits: weather matters, and clouds, dust, or haze can degrade performance. Israel says the successful intercepts have already triggered new contracts—reportedly over half a billion dollars—to expand production. If the system continues to perform under varied conditions, it could reshape how air defenses manage high-volume attacks. Oil markets watching Strait of Hormuz That broader escalation is also pushing politics in allied capitals. Canada’s Prime Minister Mark Carney said Ottawa supports Washington’s goal of preventing Iran from obtaining a nuclear weapon, even as he stressed Canada is not participating militarily and was not involved in U.S. planning. Carney’s comments, delivered during a trip to India, sparked contrasting reactions at home: Conservatives voiced support for the U.S. and Israel’s actions, the Bloc urged caution and raised concerns about authorization and international law, and the NDP condemned the strikes as a dangerous escalation while calling for diplomacy. Meanwhile, Iran has carried out retaliatory strikes against Israel and against several Gulf countries that host U.S. bases—moves Canada’s foreign minister Anita Anand condemned, urging restraint and an end to the exchanges. AI infrastructure spending hits overdrive Now to the economic pressure point: oil. Traders are bracing for volatility as markets reopen, and analysts say the biggest risk isn’t simply a drop in Iran’s exports—it’s what happens if the conflict makes the Strait of Hormuz unsafe. Iran is a major producer and exporter even under sanctions, with a large share of its crude reportedly moving to China via so-called “shadow” shipping. But multiple analysts say global markets can probably absorb the loss of Iranian barrels in isolation, at least for a time, because supply has been relatively ample. The chokepoint is Hormuz. Roughly a fifth of global oil demand flows through that narrow corridor, along with a significant share of the world’s LNG exports—especially from Qatar. Former White House energy adviser Bob McNally warned traders may be underpricing the danger, projecting oil could jump several dollars per barrel quickly, and—if shipping is threatened for any sustained period—prices could surge toward triple digits. Even a partial disruption can have outsized effects: higher insurance costs, diverted tankers, and panic stocking by governments and refiners. The U.S. could draw down the Strategic Petroleum Reserve, but analysts caution that a full Hormuz crisis could overwhelm strategic stocks if it’s large and long-lasting. OpenAI’s $110bn funding round Let’s shift to the other mega-story of 2026: the AI infrastructure boom, where the numbers are getting almost surreal. TechCrunch is out with a sweeping look at the “capex crunch”—the data centers, GPUs, cloud capacity, and power generation needed to train and run modern AI systems. Nvidia CEO Jensen Huang has suggested total AI infrastructure spending could reach three to four trillion dollars by the end of the decade. What’s driving it is not just demand for AI products, but also how companies are financing growth. The report describes a web of cloud commitments, GPU allocations, and even GPU-for-equity arrangements—structures that work best when both compute and private shares are scarce. If momentum slows, these circular deals could invite scrutiny. And the buildouts are enormous. Among hyperscalers, projected 2026 capital spending alone is eye-watering: Amazon around $200 billion, Google roughly $175 to $185 billion, and Meta about $115 to $135 billion—adding up to nearly $700 billion for one year. The bottlenecks aren’t just chips. It’s power, land, permitting, and grid upgrades. The article also flags local environmental impacts—pointing to allegations around emissions from a hybrid data-center-and-power project linked to xAI in South Memphis, Tennessee. Whether these investments pay off is the big tension: companies are betting that tomorrow’s AI revenue will justify today’s construction bill. Nvidia pours money into photonics That spending race connects directly to today’s biggest funding headline: OpenAI has launched a new round aiming to raise $110 billion, valuing the company at $730 billion pre-money—about $840 billion on a fully diluted basis. The round is expected to close ahead of a potential OpenAI IPO later in 2026. Amazon is set to lead with a planned $50 billion total investment—$15 billion up front, and another $35 billion tied to conditions. Nvidia and SoftBank are each committing $30 billion. OpenAI says the Amazon deal includes two gigawatts of compute capacity powered by Amazon’s Trainium chips, and makes AWS the exclusive third-party cloud provider for OpenAI Frontier, its enterprise platform for building and managing AI agents. OpenAI also emphasized that its existing relationship with Microsoft remains in place: Microsoft stays the exclusive cloud provider for OpenAI APIs and continues hosting OpenAI’s first-party products on Azure. OpenAI is also citing scale to justify the raise: more than 900 million weekly active ChatGPT users, over nine million paying business users, and rising usage of Codex. In other words, the company is telling investors: the demand is already here—we just need the factories. Vietnam launches broad AI law And those “factories” increasingly depend on light as much as electricity. Nvidia announced it will invest a combined $4 billion in two U.S. photonics firms—$2 billion each into Lumentum and Coherent—to strengthen research pipelines and supply chains for AI infrastructure. Both companies make optics and photonics technologies that move data at high speeds inside and between data centers—think lasers, optical networking components, and silicon photonics. Nvidia described the agreements as multi-year strategic partnerships that include multibillion-dollar purchase commitments and future capacity rights for advanced laser components. Jensen Huang said the goal is to advance silicon photonics to build the next generation of what he called “gigawatt-scale AI factories.” Translation: the limiting factor isn’t only compute chips anymore—it’s the entire plumbing that moves data fast enough to keep those chips busy. Canada and India reset ties Two quick items to close. I

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Brain cells learn Doom gameplay - Cortical Labs trained living human neurons on a chip to play Doom in about a week, using microelectrode arrays and a new Python interface—key keywords: biological computer, neurons-on-chip, Doom, training. OpenAI lands massive funding round - OpenAI says it raised $110B led by Amazon, with Nvidia and SoftBank joining, at a $730B pre-money valuation; ChatGPT reportedly tops 900M weekly users—keywords: funding, valuation, AWS, frontier AI. AI infrastructure boom and risks - A parallel gold rush is underway for compute, data centers, GPUs, and power, with trillion-dollar forecasts and environmental scrutiny—keywords: capex, hyperscalers, data centers, power grid, emissions. Pentagon deal reshapes AI safety - Sam Altman says OpenAI reached a Pentagon agreement with contract “red lines” barring autonomous weapons and domestic mass surveillance, amid a federal phase-out of Anthropic—keywords: safety stack, safeguards, defense AI, surveillance. Sleeping sickness gets single-dose pill - EU regulators endorsed Sanofi’s acoziborole for sleeping sickness: a single-dose, three-pill treatment that could speed elimination efforts in Congo and beyond—keywords: tsetse fly, DNDi, WHO, single dose. Gut virus markers and colon cancer - Researchers linked colorectal cancer to previously unknown prophages inside Bacteroides fragilis, raising the possibility of adding viral markers to stool screening—keywords: microbiome, prophage, screening, FIT test. Iran conflict, drones, and IAEA - The U.S. used one-way attack drones in strikes on Iran as Canada backed U.S. aims but stayed out militarily; the IAEA says it lacks access to bombed sites and can’t verify uranium stocks—keywords: LUCAS, enrichment, Grossi, verification. Trump tariffs blocked, markets swing - The U.S. Supreme Court struck down broad Trump tariffs under IEEPA, but new temporary global levies revived uncertainty, jolting currencies and pushing gold higher—keywords: trade law, tariffs, dollar, gold, supply chains. Episode Transcript Brain cells learn Doom gameplay Let’s start with the day’s most mind-bending tech story. An Australian company, Cortical Labs, says it has trained living human neurons—grown directly on a microchip—to play the classic first-person shooter Doom. The setup uses microelectrode arrays to both stimulate the neurons and read their electrical activity, turning a dish of living cells into a kind of “biological computer.” What’s new this time isn’t just the game choice—Doom is dramatically more complex than Pong, which the same group showcased back in 2021. The bigger shift is accessibility: Cortical Labs built a new interface that developers can program using Python. An independent developer with limited biology background reportedly used those tools to get the neuron-chip interacting with Doom within days. Researchers say performance isn’t anywhere near human-level gaming, but it beat random behavior, and some experts see the demo as a real step forward in training living neural systems. The unanswered question is still a big one: we can observe the outputs, but we don’t fully understand how the neurons are representing the task—especially something as visual as a game screen. OpenAI lands massive funding round Now to the major headline in AI business: OpenAI says it has secured $110 billion in new funding, valuing the company at a $730 billion pre-money valuation. According to CEO Sam Altman, Amazon is leading the round with a $50 billion commitment, while Nvidia and SoftBank have each pledged $30 billion. The Amazon money is structured: an initial $15 billion, followed by another $35 billion over the coming months if preset conditions are met. Altman also says additional investors are expected to join as the round continues. He framed the cash and partnerships as fuel for global expansion, bigger infrastructure, and a stronger balance sheet—essentially, the plumbing required to bring what he calls “frontier AI” into everyday use at worldwide scale. Altman also shared new usage numbers: ChatGPT now reportedly has more than 900 million weekly active users and over 50 million consumer subscribers. Whether you see that as exhilarating, unsettling, or both, it underlines a shift the industry keeps hinting at: the race isn’t only about smarter models—it’s about who can scale reliably and turn that scale into products people actually depend on. AI infrastructure boom and risks That scaling story is tightly tied to cloud and compute—and OpenAI is reshaping its partnerships. As part of a multiyear deal with Amazon, AWS will become the exclusive third-party cloud distribution provider for OpenAI Frontier. The companies say they’ll jointly deliver advanced AI capabilities for enterprises. OpenAI and AWS are also expanding an existing multiyear agreement—reportedly adding $100 billion over eight years—plus work on customized models for Amazon developers building customer-facing applications. OpenAI also says it’s expanding its partnership with Nvidia. At the same time, the company insists its long-standing relationship with Microsoft remains “strong and central.” In other words: OpenAI is widening the circle, but it’s not publicly cutting old ties. Pentagon deal reshapes AI safety Stepping back, a broader infrastructure boom is accelerating alongside AI products. TechCrunch reports that the real frenzy now includes data centers, power generation, GPUs, and the construction capacity to keep it all moving. Nvidia CEO Jensen Huang has projected that $3 to $4 trillion could be spent on AI infrastructure by the end of the decade. The piece traces how today’s compute alignments were shaped by early deals—like Microsoft’s first big OpenAI investment and the way cloud credits became a form of financing as training costs exploded. It also points to increasingly unconventional arrangements: GPU-for-equity structures, giant multi-year compute contracts, and a kind of circular market where scarce chips and scarce private stock are exchanged to keep expansion on schedule. There’s also a harder edge to this story: environmental impact and local backlash. When you mix data-center growth with power plants, emissions, and grid constraints, AI stops being a purely digital conversation. The big question hanging over all of it is straightforward: can the industry prove that this extraordinary spending will generate returns that justify the scale—and the tradeoffs? Sleeping sickness gets single-dose pill On the government side of AI, OpenAI says it has now reached an agreement with the U.S. Department of War—the Pentagon—after a week of very public tensions involving rival Anthropic. According to reporting by Fortune, Altman told employees the government will allow OpenAI to keep control of its “safety stack,” and would not force the company to override model refusals. Altman also described key limits: OpenAI would choose which models are deployed and where, and deployments would be restricted to cloud environments—not “edge systems” like aircraft or drones. Most notably, he said the Pentagon would include OpenAI’s “red lines” in the contract, including prohibitions on using AI for autonomous weapons, domestic mass surveillance, or critical decision-making. This comes as President Trump ordered federal agencies to stop using Anthropic technology, with a six-month phase-out. The bigger takeaway is that Washington is trying to standardize what it can demand from AI providers—and AI providers are trying to define what they simply won’t do, even under government pressure. Gut virus markers and colon cancer Turning to health and medicine, European drug regulators have backed a major simplification in treating sleeping sickness—also known as human African trypanosomiasis. A committee at the European Medicines Agency endorsed acoziborole, a pill made by Sanofi, in a step expected to help the drug reach patients first in the Democratic Republic of Congo and later across other affected regions. The potential breakthrough is practical: it’s taken as three pills at once, in a single dose. That’s a dramatic change from current approaches that can require long hospital stays, complex staging, and even spinal taps to determine the right regimen. Sleeping sickness is spread by tsetse flies in rural sub-Saharan Africa. Early symptoms can mimic the flu, but untreated infections can invade the nervous system, disrupt sleep cycles, and become fatal. A vaccine has been difficult because the parasite can change its outer proteins, dodging immune responses. In a study of about 200 patients in Congo and Guinea, more than 95% of those treated with acoziborole were considered cured 18 months later. The drug can be used for people 12 and older, and for both early and advanced infections—removing the need for spinal taps. Sanofi says it will donate doses to the World Health Organization so patients receive it for free. Researchers caution there are still unknowns, including where the parasite may be hiding, but supporters argue this could meaningfully speed efforts to stop transmission by 2030. Iran conflict, drones, and IAEA Another medical development could reshape cancer screening down the road. A Danish research team studied why the gut bacterium Bacteroides fragilis is often associated with colorectal cancer even though it’s common in healthy people. Their finding: cancer-linked strains didn’t appear to come from a single inherited bacterial lineage. Instead, the strongest signal involved “prophages”—viruses that embed themselves int

Please support this podcast by checking out our sponsors: - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Brain chips and thought decoding - Researchers at Stanford used a microelectrode BCI to translate imagined speech into text, with inner-speech decoding reaching up to 74% accuracy in structured tasks—raising privacy and ethics questions around thought decoding. Biological computers playing Doom - Australian firm Cortical Labs trained living human neurons on a chip to play Doom using a new Python-based interface, a notable step for biological computing and hybrid AI systems. OpenAI funding and AI power - OpenAI announced $110B in new backing from Amazon, Nvidia, and SoftBank at a $730B pre-money valuation, alongside claims of 900M weekly ChatGPT users—highlighting the infrastructure race for frontier AI. Pentagon pressures Anthropic over Claude - The U.S. Defense Department warned Anthropic to remove restrictions on military use of Claude or risk contract termination and a potential “supply chain risk” label, reviving debate over AI safeguards and the Defense Production Act. Middle East strikes on Iran - The U.S. and Israel carried out strikes on Iran, with Washington citing “imminent threats” and Tehran reporting explosions in multiple cities—an escalation with uncertain next moves and regional risk. New HIV prevention shot in Kenya - Kenya began rolling out lenacapavir (LEN), a free, long-acting HIV prevention injection given twice a year, supported by shipments via Gilead, the Global Fund, and additional planned U.S. doses. Single-dose pill for sleeping sickness - European regulators endorsed Sanofi’s acoziborole, a three-pill, single-dose treatment for sleeping sickness that could help eliminate transmission by simplifying care and avoiding spinal taps for staging. In-utero stem cells for spina bifida - UC Davis researchers reported early safety results for an in-utero placenta-derived stem-cell add-on during fetal spina bifida repair, with no major complications and reversal of hindbrain herniation in six newborns. India enters global 6G standards - India says it has joined 6G global standards work through ITU and 3GPP, pushing “Ubiquitous Connectivity,” targeting 10% of global 6G patents, and proposing stronger SIM and app-binding measures to curb fraud. Social media addiction lawsuit trial - A 20-year-old lead plaintiff testified in a major U.S. trial accusing Meta and YouTube of designing addictive platforms that harm youth mental health, focusing on features like infinite scroll, autoplay, and beauty filters. Episode Transcript Brain chips and thought decoding Let’s start in the fast-moving intersection of brains and machines. At Stanford, researchers are getting closer to what many people loosely call “mind reading”—but with a practical goal: restoring communication for people who can’t speak. In one study, a 52-year-old stroke survivor, identified as participant T16, had a microelectrode array implanted in the front of her brain. An AI system then translated neural activity linked to imagined speech into real-time text on a screen. Three ALS patients also participated. The big question was whether a brain-computer interface can decode not just attempted speech—when someone tries to move the muscles of speaking—but also inner speech, the silent voice in your head. In structured sentence-imagery tasks, accuracy climbed as high as 74%. But the system struggled when participants generated more spontaneous inner speech, and for open-ended prompts the output largely fell apart into gibberish. Researchers also used tasks like counting colored shapes to tease out internal number-words, detecting related traces in motor cortex activity. The takeaway: inner speech and attempted speech appear strongly correlated in motor cortex, but inner-speech signals are weaker. Separately, experts like UC Davis neuroengineer Maitreyee Wairagkar say the pace is accelerating—and predict real-world commercialization in the next few years, as companies including Neuralink push consumer-oriented brain chips. Researchers also think progress could come from sampling many more neurons than today’s systems, and from decoding signals in additional brain regions—important for stroke survivors whose motor cortex may be damaged. Biological computers playing Doom And then there’s the story that sounds the most surreal: biological computers. Australian company Cortical Labs says it trained living human neurons grown on a chip to play the classic first-person shooter Doom—in about a week. The neurons sit on microelectrode arrays that can both stimulate the cells and read their electrical activity. Cortical Labs had previously shown a neuron-chip playing Pong back in 2021, but that took years of work and used large clumps of cells. This time, the demo used roughly a quarter as many neurons and—crucially—introduced a more accessible interface that developers can program using Python. An independent developer, Sean Cole, reportedly trained the system to interact with Doom within days. To be clear, it’s not beating human gamers. But researchers say performance was better than random firing, and they’re emphasizing the engineering leap: making living neural hardware easier to program. Independent experts called it a real step forward, while also pointing out the obvious mystery—scientists still can’t fully explain how those neurons represent the game environment in the first place. OpenAI funding and AI power Staying with AI, but shifting to business and geopolitics: OpenAI says it has secured a massive new funding package. CEO Sam Altman announced $110 billion in new funding from Amazon, Nvidia, and SoftBank, valuing OpenAI at a $730 billion pre-money valuation. Amazon is leading with a $50 billion commitment, with an initial $15 billion up front and more to follow under preset conditions. Nvidia and SoftBank are each committing $30 billion. Altman also claimed ChatGPT now exceeds 900 million weekly active users and has more than 50 million consumer subscribers—numbers that, if accurate, underline just how quickly generative AI has moved from novelty to habit. On the partnership front, Amazon Web Services will become the exclusive third-party cloud distribution provider for OpenAI Frontier, aimed at delivering advanced AI tools to enterprises. OpenAI and AWS are also expanding their existing multiyear deal by another $100 billion over eight years. OpenAI says this doesn’t change its relationship with Microsoft, calling that partnership “strong and central.” Pentagon pressures Anthropic over Claude Meanwhile in Washington, the politics of AI deployment are getting sharper. According to the Associated Press, Defense Secretary Pete Hegseth gave Anthropic an ultimatum: allow its Claude technology to be used by the military without restrictions by a deadline, or risk losing its government contract. Officials also warned they could label Anthropic a “supply chain risk,” and there was talk of invoking the Defense Production Act—an extraordinary move that legal experts say would be unprecedented if used to override a company’s AI safety limits. Anthropic has been described as the last major peer not supplying tech to a new internal U.S. military network, with CEO Dario Amodei citing concerns about unchecked uses like fully autonomous armed drones and AI-enabled mass surveillance. The Pentagon says it’s not seeking mass surveillance or weapons without human involvement, but the standoff highlights the unresolved question: who gets final say over safeguards when national security is invoked? Middle East strikes on Iran Now to the Middle East, where a major escalation is unfolding. The United States and Israel carried out strikes on Iran on Saturday, following months of rising tensions and repeated warnings from President Donald Trump tied to Iran’s nuclear and ballistic missile programs. In a video posted on social media, Trump said the U.S. had begun “major combat operations,” framing the objective as eliminating imminent threats and targeting Iran’s missile capability and naval forces, as well as Tehran’s proxy networks. Israel’s defense minister said Israel launched a pre-emptive attack to remove threats to the country. Iran reported blasts in multiple cities including Tehran and Isfahan, with early reports citing casualties but limited clarity on targets. Israeli air defenses were reportedly intercepting missiles launched from Iran, while air-raid sirens sounded across Israel. Israel closed its airspace to civilian flights, and the U.S. embassy in Qatar issued a shelter-in-place warning. This is a developing situation, and what matters next is the scale of retaliation, the safety of civilians, and whether diplomatic channels—recently reopened in February—can prevent a wider regional conflict. New HIV prevention shot in Kenya Turning to public health—there are two major developments in Africa that could change how care is delivered. First, Kenya has begun administering lenacapavir, or LEN, a long-acting HIV prevention injection that can protect people for six months at a time. The shots will be offered free to eligible individuals and given twice a year at selected public health facilities in priority counties. Health Minister Aden Duale launched the rollout in Nairobi and emphasized the burden among young people aged 15 to 24. Authorities also say pregnant and breastfeeding mothers can use the drug safely, and that side-effect monitoring systems are in place. Kenya received an initial 21,000 doses through an arrangement involving Gilead Sciences and the Global Fund, with more expected in the coming months—including additional doses from the U.S.

Today's topics: In-utero stem cells for spina bifida - A first-of-its-kind fetal surgery trial used placenta-derived stem cells for myelomeningocele, reporting no major complications and reversal of hindbrain herniation; published in The Lancet (2026). New cancer immunotherapy for solid tumors - Yale researchers boosted CAR-NK cells with the OR7A10 gene, improving tumor infiltration and reducing exhaustion in mouse models of breast, colon, and ovarian cancer; Nature study points toward off-the-shelf immunotherapy. Kenya rolls out twice-yearly HIV prevention - Kenya began offering free lenacapavir (LEN) PrEP injections that protect for six months, targeting high-risk groups including youth and pregnant or breastfeeding mothers, with side-effect monitoring and phased county rollout. HIV vaccine trial rebooted in Cape Town - South Africa’s BRILLIANT 011 Phase 1 HIV vaccine trial restarted after major funding cuts, testing two immunogens plus adjuvant to spark broadly neutralising antibody precursor cells using leukapheresis, sequencing, and flow cytometry. Single-dose pill for sleeping sickness - European regulators backed Sanofi’s acoziborole—three pills taken once—for sleeping sickness, potentially removing the need for spinal taps and long hospital stays; DNDi and WHO partners aim to accelerate elimination in Congo and beyond. Pentagon pressures Anthropic over Claude - Defense Secretary Pete Hegseth reportedly told Anthropic to remove restrictions on military use of Claude or lose its contract, raising unprecedented questions about the Defense Production Act, AI safeguards, and supply-chain risk labeling. Iran-US nuclear talks in Geneva - The U.S. and Iran held a third round of indirect nuclear talks via Oman, as U.S. forces mass in the region and Tehran insists on enrichment rights; sanctions relief and IAEA access remain central sticking points. Pakistan-Afghanistan clashes escalate sharply - Pakistan and Afghanistan traded airstrikes and cross-border attacks, with Islamabad citing TTP militancy and Kabul alleging civilian casualties; the Durand Line dispute and deportation tensions deepen the crisis. India steps into global 6G standards - India says it has joined 6G standard-setting through ITU and 3GPP for the first time, pushing ‘Ubiquitous Connectivity,’ building research corridors, and targeting 10% of global 6G patents alongside new anti-fraud SIM rules. Social media addiction lawsuit goes to trial - In Los Angeles, a lead plaintiff testified that YouTube and Instagram features like autoplay and infinite scroll fueled addiction and mental-health harm, kicking off the first bellwether trial in litigation involving 1,600+ plaintiffs. https://www.rfi.fr/en/africa/20260227-kenya-to-offer-patients-free-six-month-hiv-breakthrough-prevention-jab https://www.nature.com/articles/d41586-026-00602-z?error=cookies_not_supported&code=603b4331-e074-4362-bbd4-5044231d94b7 https://news.yale.edu/2026/02/25/cracking-holy-grail-challenge-cancer-cell-therapy https://apnews.com/article/iran-us-war-geneva-talks-nuclear-c1eb17f570b059f34071937c3f310fb6 https://apnews.com/article/sleeping-sickness-sanofi-9dfce81e3cf101e04bbfc56a9736cc0e https://apnews.com/article/anthropic-military-ai-hegseth-department-of-defense-f05674f7195051ab843e5087d12c8cf8 https://abcnews.com/International/wireStory/latest-fighting-afghanistan-pakistan-130558888 https://telecom.economictimes.indiatimes.com/news/policy/india-on-global-6g-standard-setting-table-for-the-first-time-jyotiraditya-scindia/128844107 https://www.dailymaverick.co.za/article/2026-02-27-meet-the-sa-scientists-who-are-refusing-to-let-hiv-vaccine-research-stall/ https://www.theguardian.com/technology/2026/feb/26/us-trial-social-media-addiction

Today's topics: Stem cells and diabetes reversal - Chinese researchers report stem-cell-derived pancreatic islet transplants that restored insulin production in individual type 1 and type 2 diabetes cases—promising, but needing larger clinical trials. HIV reservoirs and new treatments - A Nature study isolates rare HIV “authentic reservoir clones” (ARCs) and shows long-term CTL pressure can slowly clear many; separately, a phase 3 ARTISTRY-1 trial tests a simplified bictegravir/lenacapavir single tablet. AI tools for brain imaging - MIT’s BrainAlignNet, AutoCellLabeler, and CellDiscoveryNet use deep learning to track and identify neurons in moving, deforming animals, easing a major microscopy bottleneck and accelerating behavior-to-brain mapping. Meta and AMD AI chips - Meta’s reported 6-gigawatt agreement for AMD MI450 chips—plus warrants tied to purchases—signals escalating AI data-center buildouts and intensifies the Nvidia-versus-AMD competition. Iran-US nuclear talks in Geneva - Iran and the US held a third round of indirect nuclear talks in Geneva via Omani mediation, amid regional military posturing, sanctions bargaining, and scrutiny over enrichment and IAEA access. US global tariff rate shift - A 10% US tariff on most global imports took effect after midnight, undercutting earlier talk of 15% and adding uncertainty following a Supreme Court ruling that struck down many prior Trump tariffs. Japan missile unit near Taiwan - Japan set a first timeline to deploy a surface-to-air missile unit to Yonaguni by March 2031, reflecting heightened Taiwan contingency planning and fresh friction with China. Ireland maritime security with allies - Ireland’s new maritime security strategy aims for deeper cooperation with France, the UK, and Nato-linked partners to protect subsea cables and counter Russia’s “shadow fleet” activity in Irish waters. Bacteria designed to attack tumors - University of Waterloo engineers modified Clostridium sporogenes to germinate in low-oxygen tumors and consume tissue from within, a potential add-on cancer therapy that could reach trials in 3–4 years. https://news.weill.cornell.edu/news/2026/02/new-strategies-aim-at-hiv%E2%80%99s-last-strongholds https://apnews.com/article/iran-us-war-geneva-talks-nuclear-c1eb17f570b059f34071937c3f310fb6 https://www.eurekalert.org/news-releases/1117529 https://www.bostonglobe.com/2026/02/24/business/trump-tariff-10-15/ https://kitchener.citynews.ca/2026/02/25/researchers-at-university-of-waterloo-develop-bacteria-to-eat-cancer-tumours/ https://www.bbc.com/news/articles/cd9gj1w2kn1o https://www.mcall.com/2026/02/24/meta-ai-chips-amd/ https://www.irishtimes.com/ireland/2026/02/24/ireland-to-deepen-co-operation-with-france-and-britain-to-protect-seas/ https://propakistani.pk/2026/02/24/scientists-in-china-successfully-reverse-type-1-and-type-2-diabetes-in-humans/ https://www.news-medical.net/news/20260225/New-single-pill-regimen-simplifies-treatment-for-resistant-HIV.aspx

Today's topics: FDA pathway for bespoke medicines - The FDA released guidance on a “plausible mechanism pathway” to evaluate ultra-rare, patient-specific genetic therapies, including gene-editing approaches, when trials are impractical. UK baby after womb transplant - The UK recorded its first birth following a deceased-donor womb transplant, spotlighting MRKH syndrome, IVF, anti-rejection care, and new options for infertility treatment. Safer base editing for cystic fibrosis - Researchers at Penn and Rice redesigned cytosine base editors to cut “bystander” DNA changes by over 80%, with promising preclinical results for mutation-specific cystic fibrosis fixes. Encrypted RCS texting iPhone-Android - Apple and Google began beta testing end-to-end encrypted RCS between iPhone and Android, bringing stronger privacy protections to cross-platform messaging via the GSMA standard. China’s humanoid robots surge - China’s humanoid robot sector is scaling fast, powered by EV-style supply chains and improved AI control, raising new questions about jobs, data privacy, and investment bubbles. ICC hearing for Rodrigo Duterte - ICC judges opened a confirmation of charges hearing for former Philippine President Rodrigo Duterte, weighing alleged crimes against humanity linked to killings in the ‘war on drugs.’ Iran-US nuclear talks and protests - Iran and the US are expected to hold another Geneva round on nuclear issues, while Iran faces renewed student protests, disputed casualty figures, and intensifying human-rights scrutiny. War’s impact on Russia-Ukraine births - Four years into Russia’s full-scale invasion, fertility rates have fallen further in both Ukraine and Russia, deepening long-term risks from aging populations and future labor shortages. Markets react to tariff upheaval - Markets dipped as investors weighed the US Supreme Court’s rollback of major Trump tariffs, shifting trade-policy uncertainty, stock movers like Novo and Domino’s, and a bitcoin pullback. https://www.statnews.com/2026/02/23/fda-rare-disease-new-guidelines-plausible-mechanism-pathway/ https://www.bbc.co.uk/news/articles/cvg53xp5857o https://www.seas.upenn.edu/stories/engineers-sharpen-gene-editing-tools-to-target-cystic-fibrosis/ https://news.un.org/en/story/2026/02/1167021 https://abcnews.com/Business/wireStory/us-futures-fall-asian-markets-higher-after-supreme-130398435 https://www.cnbc.com/2026/02/24/russia-ukraine-birth-rate-fertility-rate-war-women-children-demographics-economy.html https://9to5google.com/2026/02/23/google-messages-encrypted-rcs-iphone/ https://theweek.com/tech/china-and-the-rise-of-the-humanoid-robots https://www.usnews.com/news/world/articles/2026-02-23/us-military-begins-withdrawing-from-main-base-in-northeast-syria-syrian-sources-say https://www.theguardian.com/world/2026/feb/22/washington-and-tehran-to-hold-more-nuclear-talks-as-protests-reignite-in-iran

Today's topics: Twice-yearly HIV prevention shot - Zimbabwe begins rolling out lenacapavir, a twice-yearly HIV PrEP injection with near-total protection in trials, targeting key populations amid stigma and adherence challenges. Project 2025 ideas in practice - Tracking groups say roughly half of Heritage Foundation’s Project 2025 blueprint is already reflected in Trump’s second-term actions, including federal staffing cuts, DEI rollbacks, and foreign aid changes. Trump’s new 15% tariff - Trump announces a 15% global import tariff using Section 122 after the Supreme Court limited his prior IEEPA tariff authority; exemptions, timelines, and refund fights are now in focus. Ukraine war losses and options - As the Ukraine invasion nears year five, new estimates highlight massive military and civilian casualties, shrinking aid flows, and renewed debate over Western troop deployments and deterrence. Iran nuclear talks amid protests - The U.S. and Iran are expected to meet in Geneva for nuclear talks as Tehran signals stockpile steps under tougher IAEA access, while student protests and regional military tensions persist. Rare earths pact: Brazil-India - Brazil and India sign a non-binding MoU on rare earths and critical minerals, emphasizing strategic autonomy, reciprocal investment, mining cooperation, and AI-linked applications. Germany-China trade shifts again - Germany’s 2025 trade data shows China again as its top trading partner, ahead of the U.S., as Chancellor Friedrich Merz prepares a Beijing trip amid EU tariff pressure and auto-industry exposure. Agentic AI spooks tech markets - A surge of autonomous “agentic” AI tools is forcing a rethink across enterprise software and services, triggering sharp stock moves and a wider debate over disruption versus hype. https://abcnews.com/International/wireStory/long-acting-hiv-drug-arrives-zimbabwe-highest-risk-130378824 https://www.bbc.co.uk/news/articles/c5yvvjw8pdvo https://abcnews.com/Business/wireStory/brazil-india-agree-boost-cooperation-rare-earths-130371382 https://www.bbc.com/news/articles/cn8z48xwqn3o https://abcnews.com/International/wireStory/russias-invasion-ukraine-unfolded-numbers-130401750 https://www.ctvnews.ca/world/russia-ukraine-war/article/ex-uk-prime-minister-johnson-calls-on-allies-to-send-noncombat-troops-to-ukraine-ahead-of-ceasefire/ https://www.usnews.com/news/world/articles/2026-02-23/us-military-begins-withdrawing-from-main-base-in-northeast-syria-syrian-sources-say https://www.theguardian.com/business/2026/feb/22/china-overtakes-us-as-germany-top-trading-partner https://www.theguardian.com/world/2026/feb/22/washington-and-tehran-to-hold-more-nuclear-talks-as-protests-reignite-in-iran https://www.france24.com/en/live-news/20260222-ai-agent-invasion-has-people-trying-to-pick-winners

Today's topics: Airlifted microreactor for military power - The U.S. Department of Defense flew an unfueled 5‑MW Ward250 microreactor on C‑17s under the Janus Program, demonstrating rapid deployment logistics, modular assembly, and TRISO/HALEU tech for remote bases. Mars rover gets GPS-like navigation - NASA upgraded Perseverance with Mars Global Localization, letting it match panoramas to orbital maps and self-locate to about 10 inches—reducing drive delays caused by Earth-Mars communication lag. Twice-yearly HIV prevention injection rollout - Zimbabwe began offering lenacapavir, a long-acting HIV PrEP injection given twice yearly, targeting key populations amid stigma and adherence challenges; donor support via PEPFAR and the Global Fund is central. Broad-protection vaccine research at Stanford - A Stanford Medicine study in Science reports a vaccine concept that extends innate immune protection for months in mice, potentially offering broader seasonal respiratory coverage via intranasal delivery alongside targeted vaccines. Trump’s new 15% global tariff - President Trump says the U.S. will impose a 15% global import tariff using Section 122 of the 1974 Trade Act after the Supreme Court struck down prior IEEPA-based tariffs, raising refund and deal-clarity questions. Germany-China trade shift and Merz visit - Germany’s 2025 trade data show China has overtaken the U.S. as Berlin’s top trading partner, as Chancellor Friedrich Merz prepares his first Beijing trip amid EU concerns over manufacturing and EV tariffs. Brazil-India rare earths cooperation pact - Brazil and India signed a non-binding MoU on rare earths and critical minerals, covering investment, exploration, mining, and AI applications—part of a broader push for strategic autonomy and diversified supply chains. Iran-US nuclear standoff and war risk - Reuters reports the U.S. and Iran are edging closer to possible conflict as diplomacy over Tehran’s nuclear program stalls, with a major U.S. regional force buildup and Israeli contingency planning in view. Boris Johnson urges troops in Ukraine - Former U.K. Prime Minister Boris Johnson argues for immediate deployment of noncombat troops to Ukraine as a signal to Putin, while the U.K. government maintains planning for a post-ceasefire deployment only. https://abcnews.com/International/wireStory/long-acting-hiv-drug-arrives-zimbabwe-highest-risk-130378824 https://abcnews.com/Business/wireStory/brazil-india-agree-boost-cooperation-rare-earths-130371382 https://www.bbc.com/news/articles/cn8z48xwqn3o https://www.mercurynews.com/2026/02/20/new-stanford-study-points-to-vaccine-that-protects-against-multiple-infections/ https://www.ctvnews.ca/world/russia-ukraine-war/article/ex-uk-prime-minister-johnson-calls-on-allies-to-send-noncombat-troops-to-ukraine-ahead-of-ceasefire/ https://www.japantimes.co.jp/news/2026/02/21/world/politics/us-iran-military-buildup-conflict-analysis/ https://www.theguardian.com/business/2026/feb/22/china-overtakes-us-as-germany-top-trading-partner https://www.space.com/space-exploration/mars-rovers/nasas-perseverance-rover-now-has-its-own-gps-on-mars-weve-given-the-rover-a-new-ability https://www.japantimes.co.jp/news/2026/02/22/world/politics/trump-us-iran-war-economy/ https://newatlas.com/military/us-air-force-airlifts-complete-nuclear-reactor/

Please support this podcast by checking out our sponsors: - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: AI malware uses Gemini live - ESET details “PromptSpy,” Android spyware that queries Google Gemini at runtime to adapt taps and settings for persistence using Accessibility and UI XML dumps. India’s bid for AI leadership - At the India AI Impact Summit, Narendra Modi pitches “Design in India, deliver to the world,” as Microsoft, Google, Amazon and OpenAI–Tata outline major AI and data-center plans. Big Tech in court over kids - Meta, TikTok and others face a wave of U.S. lawsuits alleging addictive design, youth harm, and predator exposure—testing Section 230, First Amendment defenses, and potential damages. US–Iran tension and Gulf buildup - A BBC analysis says the U.S. naval posture—anchored by the USS Abraham Lincoln and movement of the USS Gerald R Ford—looks like more than signaling as talks with Iran appear stuck. Nasal “universal” vaccine in mice - Stanford-led research in Science reports a nasal formulation that boosts innate immunity and protected mice broadly against respiratory pathogens, with signals it may also reduce allergic asthma. Cats’ cancer genome map insights - A Science study sequences 493 cat tumors across 13 cancers, finding shared driver genes like TP53 and parallels between feline mammary cancer and human breast-cancer subtypes. Banana blight resistance breakthrough - University of Queensland researchers locate STR4 Fusarium wilt resistance on banana chromosome 5, enabling marker-assisted breeding to protect a $140B crop and global food security. Robots show China’s humanoid push - China’s Lunar New Year gala showcased humanoid parkour and flips, raising questions about real-world autonomy, military implications, and Europe’s strategy in the robot race. Google’s Lyria 3 AI music - Google launches Lyria 3 for YouTube Shorts “Dream Track,” expanding AI-generated, royalty-free music while copyright and voice-likeness disputes remain unsettled. Episode Transcript AI malware uses Gemini live We’ll start in cybersecurity, because this one is a genuine change in tactics. Security firm ESET says it has found what appears to be the first known Android malware that uses generative AI during runtime to adjust its behavior on the fly. The family is called PromptSpy. In short: it abuses Google’s Gemini model to help it persist across different Android devices, where the steps and menu labels can vary wildly by manufacturer. ESET says the malware sends Gemini a prompt plus an XML dump of what’s on screen—essentially a map of buttons, labels, and coordinates. Gemini replies with step-by-step tap instructions in a JSON-like format, and the malware carries them out using Android’s Accessibility Service. The immediate goal is surprisingly specific: “pinning” itself in the Recent Apps list so Android is less likely to shut it down and it survives “clear all” cleanups. Beyond the AI novelty, PromptSpy is still classic spyware: remote access via a built-in VNC module, screen recording and screenshots, monitoring what app is in the foreground, and even intercepting lockscreen credentials. ESET also notes nasty anti-removal tricks, like invisible overlays that block uninstall buttons, sometimes forcing victims to reboot into Safe Mode to remove it. It’s not clear yet how widespread it is, but the takeaway is clear: generative AI isn’t just writing phishing emails—it’s starting to automate interactive, device-specific attack steps in real time. India’s bid for AI leadership Now to AI as economic strategy. India’s Prime Minister Narendra Modi used the India AI Impact Summit in New Delhi to pitch the country as a central builder in the global AI ecosystem—his message to companies was essentially: design and develop in India, then ship to the world. Modi framed India as a cost-effective hub with a track record in digital public infrastructure, from digital ID systems to fast online payments. The summit pulled in heavyweight voices, including French President Emmanuel Macron, Google CEO Sundar Pichai, and U.N. Secretary-General António Guterres. Guterres, notably, pushed for a three-billion-dollar fund to help lower-income countries build baseline AI capacity—skills training, access to data, and affordable compute—warning the future of AI shouldn’t be steered by only a handful of nations, or a handful of billionaires. Modi, for his part, leaned hard into India as a bridge between advanced economies and the Global South, using the phrase “democratize AI” as a theme of inclusion and empowerment. Big Tech in court over kids The investment numbers being discussed around India are enormous. Microsoft has announced about 17.5 billion dollars over four years. Google is committing 15 billion over five years and says it will open its first AI hub in India. Amazon has pledged 35 billion by 2030 tied to AI-driven digitization. And OpenAI CEO Sam Altman said OpenAI will collaborate with India’s Tata Group on AI initiatives, including data-center infrastructure—while also endorsing “democratization of AI” as the safest, fairest path. Still, India’s ambitions come with constraints: limited access to advanced chips, not enough data-center capacity yet, and the sheer complexity of building frontier models across hundreds of local languages. So the near-term story may be less “India launches the world’s top large model,” and more “India becomes a massive build-and-deploy platform” for AI products, infrastructure, and multilingual applications. And yes, the summit had some messy moments—reports of long lines, delays, and even theft that organizers said was later resolved. One private university was expelled after displaying a commercially available Chinese-made robotic dog while presenting it as homegrown innovation. There was also an awkward viral photo moment when Modi asked participants to hold hands aloft; some, including Altman and Anthropic CEO Dario Amodei, didn’t join hands—Altman later said he was simply confused. Finally, Bill Gates withdrew from a scheduled keynote without a public reason, with the Gates Foundation saying the decision was to keep focus on summit priorities amid renewed scrutiny of Gates’ past ties to Jeffrey Epstein. US–Iran tension and Gulf buildup Staying with tech—this time, the courtroom. Social media companies including Meta and TikTok are facing a growing wave of lawsuits across the U.S., alleging platforms deliberately use addictive design features that harm children’s mental health and fail to protect kids from predators and dangerous content. What’s new here is procedural but important: these cases are increasingly reaching juries, not just being argued in motions. Two trials are underway in Los Angeles and New Mexico, and a major multidistrict case in Oakland is set up with public school districts as bellwether plaintiffs—meaning early outcomes could shape thousands of related claims. In the Los Angeles case, Meta and YouTube remain as key defendants, and Meta CEO Mark Zuckerberg has testified—pointing to age limits under 13, detection efforts for misstated ages, and disputing the idea that Meta’s products are “addictive.” New Mexico’s attorney general, Raúl Torrez, is pushing for stronger age verification, changes to recommendation systems, and faster removal of bad actors, while criticizing end-to-end encryption as a barrier to safety monitoring. Meta’s position is that encryption is broadly supported for privacy and security. Social psychologist Jonathan Haidt, author of The Anxious Generation, argues Zuckerberg’s first jury trial appearance could be a turning point. Haidt says the sharper legal strategy is focusing less on individual posts and more on product design—features that maximize engagement, dopamine-driven loops, and alleged rabbit-hole recommendations. The legal fight will test where Section 230 protections end and where product-liability-style claims can begin. Regardless of who wins, the process looks set to be long, expensive, and potentially transformative for how platforms are built—and how they’re regulated in the U.S. Nasal “universal” vaccine in mice Now to geopolitics. A BBC report suggests the U.S. military buildup in the Gulf is starting to look like preparation for possible action, not just signaling. The arrival of the USS Abraham Lincoln carrier strike group near Iranian waters is one marker. Another is the USS Gerald R Ford heading east after being seen near the Strait of Gibraltar—part of what the report calls “layered” options for Washington. The analysis argues that indirect U.S.–Iran talks may have reached a deadlock, with Tehran reading U.S. conditions as demands for capitulation. Those conditions, as described by U.S. Secretary of State Marco Rubio, include ending uranium enrichment, curbing ballistic missile range so Israel is not threatened, halting support for armed groups across the region, and changes to the Islamic Republic’s treatment of citizens. From Iran’s perspective, the report says, those demands cut into three pillars of deterrence: the nuclear program’s threshold capability, the missile program as a substitute for an aging air force, and regional proxy alliances sometimes described as an “Axis of Resistance.” The piece also warns of severe risks for Iran if conflict escalates—leadership targeting, instability around succession, and economic shocks that could amplify public anger in a country already strained by sanctions and inflation. For Washington, the risk is miscalculation: capability doesn’t guarantee control once real fighting starts, and recent conflict dynamics h

Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Nasal universal vaccine in mice - A Stanford-led *Science* study reports a nasal “universal vaccine” that boosted innate immunity in mice, protecting against SARS‑CoV‑2, other coronaviruses, bacteria, and even allergic asthma—raising big questions about human safety and efficacy. Personalized mRNA vaccine for TNBC - A *Nature* paper from the TNBC‑MERIT phase 1 trial shows an individualized neoantigen mRNA vaccine (RNA–LPX) is feasible after surgery and standard therapy in early triple-negative breast cancer, producing durable multi-epitope T‑cell responses with manageable reactogenicity. Kenya rolls out lenacapavir PrEP - Kenya plans an early-March rollout of lenacapavir, a twice‑yearly injectable HIV prevention drug shown to cut transmission risk by more than 99.9%, amid shifting global health funding and continued high HIV burden in eastern and southern Africa. India’s AI summit and investments - At the India AI Impact Summit in New Delhi, Prime Minister Narendra Modi pitched India as a global AI hub, with major commitments from Microsoft, Google, and Amazon and calls for “inclusive, multilingual” AI alongside Global South capacity-building proposals. Pax Silica semiconductor partnership - India joined Pax Silica, a U.S.-led framework to strengthen semiconductor and critical-tech supply chains, reflecting deeper U.S.–India strategic alignment and efforts to reduce reliance on China-dominated manufacturing ecosystems. Social media lawsuits over child safety - Meta, TikTok, and others face expanding U.S. litigation alleging addictive design and failures to protect children from harmful content and predators, with jury trials and bellwether cases testing First Amendment and Section 230 defenses. UK 48-hour takedown law - The UK government proposes a rule forcing platforms to remove non-consensual intimate images within 48 hours, with steep fines up to 10% of global revenue and stronger re-upload prevention—treating the abuse like terrorist and child sexual abuse content. Sudan Darfur violence genocide warning - U.N.-backed experts say RSF actions around el‑Fasher in Darfur show “hallmarks of genocide,” citing mass killings, sexual violence, siege conditions, and ethnically targeted attacks—fueling calls for accountability and civilian protection. AI music tools from Google Apple - Google and Apple are mainstreaming generative AI in music: Gemini can create short tracks with DeepMind’s Lyria 3, while Apple Music’s “Playlist Playground” turns prompts into playlists—intensifying copyright, rights, and industry disruption debates. Cat cancer genome map insights - A large feline cancer genomics project sequenced 493 cat tumors and found human-like driver mutations—especially TP53 and breast-cancer-linked FBXW7—supporting “One Health” research and precision oncology across species. Episode Transcript Nasal universal vaccine in mice Let’s start with that surprising vaccine research. A Stanford-led team, publishing in *Science* on February 19th, reports a nasally delivered “universal vaccine” concept that protected mice for at least three months against a range of respiratory threats—SARS‑CoV‑2 and other coronaviruses, plus bacteria that can trigger serious lung infections. What’s different here is the target: instead of teaching the adaptive immune system to recognize one pathogen, the formulation “supercharges” innate immunity—those early, broad defenses your body uses before it knows exactly what it’s fighting. The vaccine combines two drugs that activate receptors on innate immune cells in the lungs, alongside a third component designed to keep that activation from fading. That sustaining piece also triggered a T‑cell population and used an immunogenic protein derived from chicken eggs; when researchers left it out, protection dropped off quickly. In these mouse experiments, four nasal doses didn’t just blunt infections—they also reduced allergic hypersensitivity to dust mites, preventing allergic-asthma-like symptoms. The proposed mechanism is a “two-bulwark” setup: strengthen the mucosal barrier to limit entry, then accelerate lung immune responses to clear what gets through. Outside experts called the data compelling, with the big caveat that safety and real-world performance in humans remain unknown. Personalized mRNA vaccine for TNBC Staying in medical research, a *Nature* paper is out with detailed results from the individualized neoantigen mRNA vaccine arm of TNBC‑MERIT—an early, first-in-human phase 1 umbrella trial in early-stage triple-negative breast cancer after surgery and standard (neo)adjuvant treatment. Here, the approach was highly personalized: each patient’s tumor was sequenced, and up to 20 tumor-specific mutations were selected as neoantigen targets. Those targets were encoded on two mRNAs and delivered intravenously via lipid nanoparticles designed to reach dendritic cells—key orchestrators of T-cell immunity. Fifteen patients consented; 14 received vaccination per protocol and were evaluable. Manufacturing was “on-demand” and, importantly, workable in routine clinical settings, with an average turnaround of about 69 days from sample receipt to vaccine release. Side effects were mainly short-lived flu-like reactogenicity—fever, chills, fatigue—mostly grade 1 to 2, with one patient discontinuing after hypotension and other symptoms. On immune readouts, all 14 patients showed vaccine-induced or vaccine-amplified T-cell responses to at least one neoantigen target, sometimes several. Many responses were multi-epitope, and most immunogenic epitopes skewed CD4-positive, though CD8 responses were also observed, including persistent neoantigen-specific CD8 T cells detectable years later in some cases. Clinically, and with the usual caution for a small, uncontrolled phase 1 study, most patients remained relapse-free at long follow-up, while recurrence analyses suggested different escape routes—like weaker initial immunogenicity, loss of antigen presentation machinery, or a recurrence arising from a genetically distinct tumor not used for vaccine design. The authors frame this as a feasibility-and-immunogenicity win that now needs controlled testing. Kenya rolls out lenacapavir PrEP One more major health story, this time in public health implementation: Kenya’s health ministry says it will begin rolling out lenacapavir for HIV prevention in early March across 15 priority regions. It’s a twice-yearly injection with reported risk reduction above 99.9% in studies—often described as game-changing, even though it’s not a vaccine in the classic sense because it doesn’t train the immune system. Kenya received an initial shipment of 21,000 doses through an arrangement involving Gilead Sciences and the Global Fund, with more continuation doses expected soon and additional supply commitments from the U.S. The rollout lands in a complicated funding environment, with broader disruption to HIV programs after U.S. aid cuts—yet Kenya and the U.S. also signed a sizable multi-year health aid agreement in December that includes HIV priorities. The big practical question now is pace and coverage: getting a highly effective tool into the communities that need it, consistently, over time. India’s AI summit and investments Turning to technology and geopolitics, India used this week’s India AI Impact Summit in New Delhi to make a clear pitch: build in India, scale to the world. Prime Minister Narendra Modi framed the country as a cost-effective AI hub powered by its experience rolling out digital public infrastructure—think national digital ID and real-time payments. The summit drew heavyweight voices, including French President Emmanuel Macron, Google CEO Sundar Pichai, and U.N. Secretary-General António Guterres. Guterres called for a $3 billion fund to help lower-income countries build baseline AI capacity—skills training, data access, and affordable computing—warning that the technology’s direction shouldn’t be set by a narrow club of nations or wealthy insiders. India’s market size is part of the magnet: nearly a billion internet users. Major investment plans were highlighted, including Microsoft’s $17.5 billion over four years, Google’s $15 billion over five years—plus its first AI hub in India—and Amazon’s $35 billion pledge by 2030 tied to AI-driven digitization. OpenAI CEO Sam Altman also said OpenAI will collaborate with India’s Tata Group on AI initiatives, including data-center infrastructure. India, meanwhile, is still chasing a homegrown, globally leading large-scale model, with constraints that include access to advanced chips, data centers, and the sheer complexity of hundreds of languages. And yes, the summit had some messy headlines: disruptions, long lines, reports of theft later said to be resolved, and the expulsion of a private university after it showcased a commercially available Chinese-made robotic dog while presenting it as original innovation. Microsoft co-founder Bill Gates also withdrew from a scheduled keynote, with the Gates Foundation saying it was meant to keep focus on summit priorities amid renewed attention to Gates’ past ties to Jeffrey Epstein. Pax Silica semiconductor partnership Alongside that AI diplomacy, India also joined Pax Silica, a U.S.-led initiative meant to tighten tech cooperation and secure supply chains among strategic partners. The focus is semiconductors and advanced manufacturing—essentially, the plumbing of modern AI and electronics. U.S. officials described the goal as reducing reliance on China-dominated manufacturing hubs and ex

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Alzheimer’s blood test timing breakthrough - Researchers at Washington University report a single blood biomarker, p-tau217, can help predict Alzheimer’s symptom onset within 3–4 years, potentially accelerating clinical trials and prevention research. Kenya’s lenacapavir HIV rollout - Kenya plans an early-March rollout of lenacapavir, a twice-yearly HIV-prevention injection cutting transmission risk by over 99.9%, amid regional epidemic pressures and shifting U.S. aid dynamics. Ukraine-Russia talks in Switzerland - U.S.-mediated Ukraine-Russia discussions in Switzerland moved into a second day with cautious expectations, as Kyiv demands security guarantees and rejects Moscow’s maximalist territorial terms. Sudan Darfur atrocities and genocide - A U.N.-backed fact-finding mission says RSF attacks around el-Fasher show hallmarks of genocide, citing mass killings, sexual violence, siege conditions, and urgent accountability needs in Sudan’s war. AGI outlook and India partnerships - DeepMind CEO Demis Hassabis says AGI is ‘on the horizon,’ urging global governance and highlighting rapid model gains plus major education and product partnerships in India. AI music tools hit consumers - Google’s Gemini adds 30-second AI music generation using Lyria 3, while Apple introduces ‘Playlist Playground’ in iOS 26.4—raising fresh copyright and platform competition questions. UK 48-hour takedown rule - The UK proposes a law forcing platforms to remove non-consensual intimate images within 48 hours, with major fines, reupload prevention, and simplified reporting to reduce victim ‘whack-a-mole.’ Digital euro and payment sovereignty - ECB board member Piero Cipollone argues a digital euro is needed as payments go online, promising legal-tender status, offline privacy features, and reduced dependence on non-European card schemes. UK alternative to card networks - British banks and policymakers are exploring a national account-to-account payment rail to lessen reliance on Visa and Mastercard, improve resilience, and potentially lower merchant fees. Japan exports surge amid tariffs - Japan’s January exports jumped 16.8% led by China and Europe, while U.S.-bound shipments fell—underscoring tariff sensitivity and the shifting geography of global demand. Episode Transcript Alzheimer’s blood test timing breakthrough First, health and medicine—starting with that Alzheimer’s development. Researchers at Washington University School of Medicine in St. Louis have published work in Nature Medicine describing what they call “clock” models that use a single blood test to estimate when Alzheimer’s symptoms are likely to appear. The key signal is a blood biomarker known as plasma p-tau217, tied to the brain’s tau pathology. In their dataset—603 older adults drawn from two long-running research cohorts—the models predicted symptom onset within roughly three to four years. One detail that stood out: the time between p-tau217 rising and symptoms showing up appears shorter in older adults than in younger ones. In the study’s examples, an elevation around age 60 lined up with symptoms about two decades later, while elevation around age 80 mapped closer to about 11 years. The practical significance is scale and speed. Blood tests are cheaper and easier than PET scans or spinal fluid sampling, and that matters for clinical trials looking for participants likely to develop symptoms within a defined timeframe. The team also released code and a research-facing web app, signaling they want others to test and build on the approach. Kenya’s lenacapavir HIV rollout Staying with health, Kenya says it will begin rolling out lenacapavir for HIV prevention in early March, focusing first on 15 priority regions. Lenacapavir is a twice-yearly injection that has shown more than a 99.9% reduction in the risk of HIV transmission in studies. It’s often discussed like a vaccine, but technically it’s a chemical prevention drug, because it doesn’t train the immune system the way vaccines do. Kenya was among nine African countries selected last year for introduction of the drug. South Africa, Eswatini, and Zambia began rollouts in December. Kenya’s health ministry says the country received an initial shipment of 21,000 doses this week through an arrangement involving manufacturer Gilead Sciences and the Global Fund. Health Minister Aden Duale says another 12,000 continuation doses are expected by April, and that the U.S. government has committed an additional 25,000 doses. The rollout arrives at a complicated moment. Eastern and southern Africa remain the epicenter of the HIV burden—UNAIDS data puts about 52% of the world’s 40.8 million people living with HIV in those regions. At the same time, U.S. aid cuts under President Donald Trump have disrupted HIV and broader health programs across Africa. Kenya and the U.S. did sign a $2.5 billion health aid deal in December—reportedly the first bilateral agreement after major changes to USAID and NGO roles—but that deal is being challenged in Kenyan court over alleged constitutional issues. Ukraine-Russia talks in Switzerland Now to geopolitics and conflict—starting with Ukraine and Russia. U.S. special envoy Steve Witkoff says talks in Switzerland produced what he called “meaningful progress,” as negotiators prepared for a second day of discussions in Geneva. Still, expectations for a breakthrough remain muted. Ukrainian President Volodymyr Zelensky has publicly pushed back on what he sees as disproportionate pressure from President Trump for Ukraine to compromise. Zelensky argues peace can’t be achieved “if victory is handed to Russia,” and says any settlement needs firm Western security guarantees, including from the United States. Russia, for its part, continues to stick to maximalist demands—reportedly including Ukraine ceding the remainder of the Donbas region, which Kyiv rejects. Moscow occupies about 20% of Ukrainian territory at this point, including large parts of eastern Donbas. Ukraine’s lead negotiator, Rustem Umerov, says the first day focused on practical mechanics of possible solutions. Zelensky says Ukraine is ready to refrain from strikes under a U.S. proposal presented to both sides. Russian media described the six-hour session as tense, with talks happening in a mix of bilateral and trilateral formats. The timing is also notable: these discussions come just a week before the fourth anniversary of Russia’s full-scale invasion, with both sides still reporting overnight drone attacks. Sudan Darfur atrocities and genocide Next, Sudan—where U.N.-backed experts are issuing one of the starkest assessments yet of the war’s impact in Darfur. An independent fact-finding mission says an October campaign by Sudan’s Rapid Support Forces, or RSF, against non-Arab communities in and around el-Fasher shows “hallmarks of genocide.” The report describes an 18-month siege that left residents exhausted and malnourished, followed by conditions and actions that investigators say were calculated to bring about physical destruction—particularly targeting the Zaghawa and Fur communities. U.N. officials say several thousand civilians were killed during the takeover of el-Fasher, and that only around 40% of the city’s roughly 260,000 residents managed to flee the attack alive. The Human Rights Office cites widespread atrocities including mass killings, summary executions, sexual violence, torture, and abductions for ransom. The report includes a claim that more than 6,000 people were killed in just a three-day span around October 25th to 27th, and says at least 300 were killed in two days at the Abu Shouk displacement camp ahead of the assault. The mission says at least three of the five Genocide Convention criteria are met, including killings, serious bodily or mental harm, and deliberately inflicting life conditions meant to destroy a protected group in whole or in part. The RSF did not respond to requests for comment in this report, and its commander has previously acknowledged abuses while disputing the scale. British Foreign Secretary Yvette Cooper says she plans to take the findings to the U.N. Security Council, arguing the world is still failing Sudan. The war began in April 2023 between the Sudanese military and the RSF, with U.N. figures putting deaths above 40,000—while aid groups warn the real toll is likely much higher. AGI outlook and India partnerships Let’s shift to technology—where the pace of change is fast, and the stakes keep rising. At the India AI Impact Summit, DeepMind CEO Demis Hassabis said artificial general intelligence—AGI—is now “on the horizon.” He framed it as potentially more transformative than the Industrial Revolution, and possibly arriving faster than many expect. Hassabis also emphasized a governance gap: it’s not clear how to ensure benefits are shared broadly, and he argued that decisions about AGI can’t be left to technologists alone. He also praised India’s AI ecosystem, calling the country a global “powerhouse,” especially in areas like efficient modeling, continual learning, and multilingual systems. DeepMind announced collaboration with the Government of India through its national partnerships program, including work with 10,000 Atal Tinkering Labs aimed at bringing AI tools into schools—an initiative targeting about 11 million students. DeepMind also highlighted a partnership with Reliance Jio to bring Gemini to Indian users. And speaking of Gemini, we’re seeing AI features land directly in everyday entertainment tools. Google says Gemini can now generate 30-se

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Ukraine-Russia peace talks in Geneva - US envoy Steve Witkoff says the Switzerland talks showed “meaningful progress,” but Kyiv remains wary as Russia holds to maximalist demands and Ukraine seeks firm Western security guarantees. Europe tightens sanctions on Russia - The EU is weighing a 20th sanctions package, including a potential ban on maritime services for Russian oil tankers and new anti-circumvention steps targeting re-exports via high-risk countries such as Kyrgyzstan. Sweden warns of hybrid threats - Sweden’s MUST intelligence service says Russia is escalating hybrid activity and risk-taking in the Baltic region, with pressure likely to persist regardless of how the Ukraine war develops. Russia upgrades long-range air missiles - RUSI analyst Justin Bronk reports wider Russian use of R-37M air-to-air missiles on Su-35s, extending theoretical engagement ranges to around 200 miles and complicating NATO air planning. US-Iran nuclear talks and threats - Indirect US-Iran nuclear talks in Geneva, mediated by Oman, produced agreement on “guiding principles,” as military posturing grows with US deployments and Iranian drills near the Strait of Hormuz. Kenya rolls out twice-yearly PrEP - Kenya received 21,000 starter doses of Lenacapavir for HIV prevention, a long-acting injectable PrEP given twice yearly, supported by Global Fund and additional expected US supply for phased rollout. New CRISPR light-based cancer test - Researchers report an ultra-sensitive optical blood sensor combining CRISPR-Cas12a, quantum dots, DNA nanostructures, and second-harmonic generation to spot trace cancer biomarkers at sub-attomolar levels. Ethiopia’s fast shift to EVs - After banning fossil-fuel car imports and cutting EV tariffs, Ethiopia has pushed EV adoption to nearly 6% of vehicles, leveraging cheap hydropower but still facing charger shortages and grid gaps. Japan exports surge despite tariffs - Japan’s January exports jumped 16.8% led by Asia and Europe, while US-bound shipments fell amid tariff pressure—markets cheered as the yen firmed and equities gained. Episode Transcript Ukraine-Russia peace talks in Geneva Let’s start with the latest on the war in Ukraine and the diplomatic push around it. In Switzerland, US special envoy Steve Witkoff said negotiations between Ukraine and Russia produced “meaningful progress,” as delegations prepared to enter a second day of talks in Geneva on Wednesday. Still, the mood music from Kyiv is cautious. President Volodymyr Zelensky has pushed back on what he sees as uneven pressure from President Donald Trump—arguing it’s “not fair” to press Ukraine to compromise without the same public scrutiny directed at Russia. The gaps remain wide. Moscow is sticking to sweeping demands, including that Ukraine hand over the rest of the Donbas region—something Ukraine rejects outright. Russia currently occupies roughly 20% of Ukrainian territory, including large parts of eastern Donbas. Zelensky says any settlement needs strong Western security guarantees, and he indicated Ukraine is prepared to refrain from strikes under a US proposal presented to both sides. Reporting from Russian media described Tuesday’s six-hour session as tense, with talks happening in a mix of bilateral and trilateral formats. Witkoff and Jared Kushner reportedly played mediation roles, while Putin aide Vladimir Medinsky led the Russian delegation. The timing is notable: these talks land just a week before the fourth anniversary of Russia’s full-scale invasion, and both sides continue to report overnight drone attacks—an unmissable reminder that diplomacy is happening in parallel with active combat. Europe tightens sanctions on Russia That diplomacy is also colliding with a harder line from Europe. EU economy commissioner Valdis Dombrovskis says the bloc is prepared to go further—potentially adopting a full ban on maritime services for Russian oil tankers even if the G7 doesn’t move as one. This is being discussed as part of the EU’s planned 20th sanctions package, which Brussels hopes to finalize around February 24th. If that maritime-services ban happens, it would effectively sideline the oil price-cap mechanism inside EU jurisdiction, because EU firms would be barred from servicing Russian tankers regardless of the sale price. Some member states are wary—Greece, for example, has warned it could accelerate “deflagging” and strengthen Russia’s shadow fleet, while also shifting advantage to competitors outside the EU. Another key idea in the package: using the EU’s Anti-Circumvention Tool for the first time, aiming to curb diversion of sensitive goods—like computer numerical machines and radios—through third countries. Kyrgyzstan is in the spotlight, after EU exports there surged from about €263 million in 2021 to €2.5 billion in 2024, raising fears some of that machinery may be finding its way to Russia’s war effort. This is all unfolding as many European leaders watch the Switzerland talks with skepticism, and as EU leaders prepare visits to Ukraine around the anniversary date. Sweden warns of hybrid threats On the security front in Northern Europe, Sweden is also sharpening its warnings. Thomas Nilsson, the head of Sweden’s military intelligence service MUST, says Russia has stepped up hybrid activity and appears more willing to take risks in Sweden’s vicinity—particularly around the Baltic Sea region. His assessment is blunt: the trend is likely to continue whether Russia “wins” or “fails” in Ukraine. Success could embolden Moscow; failure, he argues, could breed desperation and renewed risk-taking. MUST’s annual review again labels Russia as the main military threat to Sweden and to NATO, warning that the danger may grow as Russia pours more resources into its armed forces and reinforces capabilities around the Baltic. Russia upgrades long-range air missiles And there’s a specific military development that defense watchers say matters for NATO air operations. RUSI analyst Justin Bronk reports that Russia is increasingly arming Su-35 fighter jets—and also Su-30SM2s—with the long-range R-37M air-to-air missile. The headline detail is range: the R-37M is believed to reach roughly 200 miles in ideal conditions, far beyond the older R-77-1’s estimated range of about 62 miles, though real-world effectiveness depends on many factors. Bronk’s point isn’t that every shot lands at maximum distance; it’s that routine fielding of a longer-reach weapon changes the threat picture and can push opposing aircraft to operate more cautiously. RUSI has also linked the missile’s Ukraine-war performance to factors like speed, seeker design, and Ukraine’s limitations in radar warning receivers—while noting NATO aircraft generally have more robust warning systems. He also estimates Russia’s Su-35 fleet has grown since 2020, despite wartime losses—suggesting Moscow has managed to replenish and expand capability in ways some early-war forecasts didn’t expect. US-Iran nuclear talks and threats Now to the Middle East, where diplomacy is active—but backed by unmistakable military signaling. A second round of indirect nuclear talks between the US and Iran has ended in Geneva, hosted at the Omani mission and mediated by Oman. Iran’s foreign minister Abbas Araqchi says the sides reached an understanding on the main “guiding principles,” but emphasized that significant work remains. The US has not yet publicly commented on the outcome. The atmosphere around these talks is tense. President Trump said he believes Iran wants a deal, but warned of “consequences” if it doesn’t—pointing to last summer’s US strikes on Iranian nuclear sites and arguing an agreement could have avoided that escalation. Iran, for its part, says it wants the discussion centered on its nuclear program and the lifting of US economic sanctions, while Washington has previously signaled it also wants to address issues like missile development. Meanwhile, BBC Verify has tracked a US military build-up in the region, including reports of the USS Gerald R Ford deploying alongside more destroyers, combat ships, and fighter jets. Supreme Leader Ayatollah Ali Khamenei rebuked US threats in characteristically sharp terms, warning that the danger isn’t only the aircraft carrier—it’s the weapon that could sink it. And Iran’s IRGC has staged a maritime drill in the Strait of Hormuz, a chokepoint for global oil shipping. Secretary of State Marco Rubio summed up where things stand: a diplomatic deal is possible, but “very difficult,” and expectations should be kept in check. Kenya rolls out twice-yearly PrEP Let’s shift to public health—starting with a major prevention rollout in Kenya. Kenya has received an initial 21,000 starter doses of Lenacapavir, a long-acting injectable medication used for HIV prevention. The nationwide rollout is planned for March 2026, with the Ministry of Health working alongside the Global Fund. Officials expect another 12,000 continuation doses by April, plus an additional 25,000 doses expected from the US government to support early implementation. This drug is drawing attention because it’s given twice a year, which could meaningfully improve adherence compared with daily oral PrEP. Kenya’s rollout will be phased through NASCOP, beginning in 15 high-burden counties and expanding in stages as systems and supply chains prove they can keep up. Lenacapavir was approved by the US FDA in June 2025 and endorsed by the WHO in July 2025. Kenya’s Pharmacy and Poisons Board registered both oral and injectable forms in January 2026. And one more detail that matters f

Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Build Any Form, Without Code with Fillout. 50% extra signup credits - https://try.fillout.com/the_automated_daily Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: UK tightens online safety rules - UK Prime Minister Keir Starmer promised faster fixes to the Online Safety Act to cover AI chatbots, curb addictive social-media design like endless scroll, and strengthen age checks. Proposals include Ofcom data-preservation rules after child deaths and tighter action against deepfakes and illegal content. AI governance moves in India - India outlined a “techno-legal” AI safety approach inspired by its Digital Public Infrastructure model, aiming for responsible AI by design rather than after-the-fact compliance. The plan includes governance guidelines, possible AI safety institutes, and “light-touch” regulation to balance innovation and risk control. US–Iran talks and military pressure - Indirect US–Iran nuclear talks in Geneva, mediated by Oman, ended with claims of agreement on guiding principles but no public US readout yet. Meanwhile, Trump administration warnings, a regional military build-up, and reported planning for potential support to Israeli strikes keep pressure high around sanctions relief, enrichment limits, and missiles. Ukraine war talks in Geneva - Ukraine and Russia are set for another US-brokered round in Geneva with low expectations as territory remains the core dispute. The fighting continues along a roughly 1,250-kilometer front, with intensifying drone and missile exchanges and a US June deadline for a settlement. Europe pushes rearmament message - Britain and Germany’s top military leaders made a rare joint public case that rearmament is a moral necessity to deter Russia, calling for “whole-of-society” defense readiness. Sweden’s intelligence assessment also warns Russia’s hybrid threats and risk-taking around the Baltic are rising. US–Hungary civilian nuclear deal - The US and Hungary signed a civilian nuclear cooperation agreement aimed at small modular reactors, fuel supply diversification, and spent-fuel management. The Rubio–Orbán deal seeks to reduce reliance on Russian nuclear technology and expands US influence in Central Europe’s energy sector ahead of Hungary’s election. New blood test detects cancer earlier - Researchers reported an ultra-sensitive optical blood sensor that detected lung-cancer-related microRNA at sub-attomolar levels using CRISPR-Cas12a, quantum dots, and low-noise second harmonic generation on MoS₂. The platform could enable earlier screening and adaptable biomarker testing for cancers and other diseases. Mini spinal cord models injury repair - Northwestern scientists built a lab-grown human mini spinal cord organoid that includes microglia, letting them model inflammation, scarring, and neuron loss after injury. Their “dancing molecules” supramolecular therapy reduced scar-like tissue and boosted neurite outgrowth, supporting future regenerative medicine trials. Episode Transcript UK tightens online safety rules Let’s start in the UK, where Prime Minister Sir Keir Starmer is promising faster action to close gaps in the Online Safety Act—especially where children and AI tools are concerned. The law became official in 2023, but it was written before today’s wave of chatbots and widely used generative AI. Starmer says the government recently “won” a battle with X after threatening action over Grok, its AI assistant, allegedly generating non-consensual sexual deepfakes. His message now is broader: tackle not just one platform, but the entire ecosystem of AI bots. The proposals being discussed would explicitly bring AI chatbots under the Online Safety Act, and go after the features many parents and researchers have criticized for years—auto-play, endless scrolling, and other design choices that can encourage compulsive use. Starmer also wants tougher measures to stop children getting around age limits, including looking at how VPNs can be used to bypass checks. There’s also a striking data-preservation element. One idea would require coroners to notify Ofcom each time a child aged 5 to 18 dies, so regulators can ensure platforms don’t erase data that could be relevant to understanding the death. In a related push tied to the Crime and Policing Bill—and a campaign known as “Jools’ Law”—companies would have to preserve potentially relevant data within five days. That’s meant to address a recurring problem: by the time families, coroners, or police ask for information, it may already be gone. The campaign was driven by Ellen Roome, whose 14-year-old son died in 2022; she suspects an online challenge may have played a role but says she hasn’t been able to access the data needed to confirm it. Technology Secretary Liz Kendall says consultation matters, but argues the UK needs the power to move quickly once choices are made—because tech policy, in her view, has moved too slowly since early Online Safety Act debates began back in 2017. Opposition parties are split on tone but not on pressure: critics from the Conservatives and Liberal Democrats call the consultation “inaction” and want tougher steps, including ideas like restricting certain platforms for under-16s and putting a potential child social-media ban to a vote in Parliament. Campaigners broadly welcome the direction, but many are still asking for stronger, clearer enforcement. AI governance moves in India Staying with AI governance, India is sketching out its own plan—one it describes as a “techno-legal” framework for AI safety. Principal Scientific Adviser Ajay Sood says the goal is to bake obligations into systems from the earliest stages of design and deployment, rather than treating compliance as a box-ticking exercise after products are already out in the world. India is taking cues from its Digital Public Infrastructure model—open, interoperable systems that helped scale identity and payments. The idea is to bring that same template to AI: practical standards, clear accountability, and potentially AI safety institutes to support oversight. Sood is advocating what he calls a light-touch approach—avoid heavy command-and-control rules that could choke innovation, but still put real guardrails around risks. These comments come as New Delhi hosts the India AI Impact Summit, with senior international figures in attendance, and as India positions itself to be a major player in “AI as a service” over the next few years. US–Iran talks and military pressure Now to Geneva, where diplomacy is busy, complicated, and closely watched. A second round of indirect nuclear talks between the United States and Iran has ended, hosted at Oman’s mission and mediated by Oman. Iran’s Foreign Minister Abbas Araqchi says there’s an understanding on broad “guiding principles,” while emphasizing that the hard work is still ahead. The US hasn’t publicly offered its own readout yet. These talks are taking place under a shadow of threats and force postures. President Donald Trump has said he believes Iran wants a deal, but warned of “consequences” if it doesn’t. He’s also pointed to last summer’s US bombing of Iranian nuclear sites, arguing a deal could have prevented that escalation. The region is also seeing an uptick in visible military activity. Reports track a US build-up that includes the aircraft carrier USS Gerald R. Ford and additional destroyers, combat ships, and fighter aircraft. Iran, for its part, is signaling it won’t be intimidated. Supreme Leader Ayatollah Ali Khamenei has publicly rebuked US warnings, and the IRGC has run maritime drills in the Strait of Hormuz—a choke point for global oil shipping. The core issue, as ever, is scope. Tehran says it wants to focus on the nuclear program and sanctions relief. Washington has previously suggested it also wants to address missile development and other regional concerns—items that Iran often treats as non-starters. Secretary of State Marco Rubio says a diplomatic outcome is possible but “very difficult,” and cautions against overselling the near-term chances. Ukraine war talks in Geneva And there’s another layer: reporting from US media says senior US military and intelligence officials are discussing what American support could look like if Israel carries out strikes on Iran—particularly against Iran’s ballistic missile program—should diplomacy fail. The discussions reportedly include practical questions like aerial refueling and potential overflight permissions. Overflight is a political minefield. Countries along potential routes—Jordan, Saudi Arabia, and the UAE—have publicly said they wouldn’t allow their airspace to be used to support strikes on Iran, and there’s no indication they’ve changed that position. At the same time, the Pentagon’s posture appears to be shifting toward more firepower in range, with plans reported to redeploy the Ford carrier group from the Caribbean into the Middle East. The message is deterrence and leverage—but it also raises the stakes around any miscalculation. Europe pushes rearmament message Geneva is also the setting for fresh, US-brokered contacts tied to the war in Ukraine. A Ukrainian delegation is traveling for talks with Russian officials just ahead of the fourth anniversary of Russia’s full-scale invasion. Expectations are restrained. The United States has reportedly set a June deadline for reaching a settlement, but the hardest questions—occupied territory, future security arrangements, and what Moscow would demand in return—remain fundamentally unresolved. On the battlefield, the pattern is grimly familiar: a long, grinding front of roughly 1,250 kilometers, continued Russian aerial attacks that hit homes and energy infrastructure, and Ukraine’s expanding abilit

Welcome to 'The Automated Daily', your ultimate source for a streamlined and insightful daily news experience. Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: -UK pushes tougher online safety -AI spending boom and worries -Ukraine peace talks in Geneva -Europe debates rearmament and deterrence -Middle East: Iran talks and Gaza plan -Lab-grown spinal cord breakthrough Subscribe to edition specific feeds: - Space news * Apple Podcast English Spanish (coming soon) French (coming soon) * Spotify English Spanish (coming soon) French (coming soon) * RSS English Spanish (coming soon) French (coming soon) - Top news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French - Tech news * Apple Podcast English Spanish French * Spotify English Spanish Spanish * RSS English Spanish French - Hacker news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French - AI news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French Visit our website at https://theautomateddaily.com/ Send feedback to feedback@theautomateddaily.com Youtube LinkedIn X (Twitter)

Welcome to 'The Automated Daily', your ultimate source for a streamlined and insightful daily news experience. Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: -Munich debates NATO’s future -Europe explores nuclear deterrence -Ukraine war and shadow attacks -Trusted Tech Alliance launches -India’s push for AI rules -AI-only social network risks -WHO condemns hepatitis B trial -New glioblastoma immunotherapy trial -Inside-out exoplanet system mystery Subscribe to edition specific feeds: - Space news * Apple Podcast English Spanish (coming soon) French (coming soon) * Spotify English Spanish (coming soon) French (coming soon) * RSS English Spanish (coming soon) French (coming soon) - Top news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French - Tech news * Apple Podcast English Spanish French * Spotify English Spanish Spanish * RSS English Spanish French - Hacker news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French - AI news * Apple Podcast English Spanish French * Spotify English Spanish French * RSS English Spanish French Visit our website at https://theautomateddaily.com/ Send feedback to feedback@theautomateddaily.com Youtube LinkedIn X (Twitter)